Infectious Conditions

Section 1 - Infectious Conditions

Published online by Cambridge University Press: 15 June 2018

Edited by

Louis Caplan and

José Biller

Show author details

Louis Caplan: Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller: Affiliation:
Loyola University Stritch School of Medicine, Chicago

Book contents

Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Type: Chapter
Information: Uncommon Causes of Stroke , pp. 1 - 76

DOI: https://doi.org/10.1017/9781316551684 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aho, K., Sievers, K. and Salo, O. P. 1969. Late complications of syphilis: A comparative epidemiological and serological study of cardiovascular syphilis and various forms of neurosyphilis. Acta Derm Venereol, 49, 336–42.Google Scholar

Aldrich, M. S., Burke, J. M., and Gulati, S. M. 1983. Angiographic findings in a young man with recurrent stroke and positive fluorescent treponemal antibody (FTA). Stroke, 14, 1001–4.CrossRef Google Scholar

Alpers, B. J. 1954. Clinical Neurology, 3rd edn. Philadelphia: FA Davis.Google Scholar

Bates, B., Choi, J. Y., Duncan, P. W., et al. 2005. Veterans Affairs/Department of Defense Clinical Practice Guideline for the Management of Adult Stroke Rehabilitation Care: Executive summary. Stroke, 36, 2049–56.Google Scholar

Bordon, J., Martinez-Vazquez, C., Alvarez, M., et al. 1995. Neurosyphilis in HIV-infected patients. Eur J Clin Microbiol Infect Dis, 14, 864–9.CrossRef Google Scholar PubMed

Brightbill, T. C., Ihmeidan, I. H., Post, M. J., Berger, J. R., and Katz, D. A. 1995. Neurosyphilis in HIV-positive and HIV-negative patients: Neuroimaging findings. Am J Neuroradiol, 16, 703–11.Google Scholar

Buchacz, K., Patel, P., Taylor, M., et al. 2004. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS, 18, 2075–9.Google Scholar

Burke, J. M. and Schaberg, D. R. 1985. Neurosyphilis in the antibiotic era. Neurology, 35, 1368–71.CrossRef Google Scholar PubMed

Centers for Disease Control and Prevention (CDC). 2002. Sexually Transmitted Diseases Treatment Guidelines 2002. Morbidity and Mortality Weekly Report, vol. 51, RR-6.Google Scholar

Centers for Disease Control and Prevention (CDC). 2015. Sexually Transmitted Diseases Treatment Guidelines Syphilis, 2015. Morbidity and Mortality Weekly Report, vol. 64, No. 3.Google Scholar

Clark, E. G. and Danbolt, N. 1955. The Oslo study of the natural history of untreated syphilis; an epidemiologic investigation based on a restudy of the Boeck–Bruusgaard material; a review and appraisal. J Chronic Dis, 2, 311–44.Google Scholar

Cordato, D. J., Djekic, S., Sanjeev, R., et al. 2013. Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population. J Clin Neurosci, 20, 943–7.Google Scholar

Danielsen, A. G., Weismann, K., Jorgensen, B. B., Heidenheim, M., and Fugleholm, A. M. 2004. Incidence, clinical presentation and treatment of neurosyphilis in Denmark 1980–1997. Acta Derm Venereol, 84, 459–62.Google Scholar

Davis, L. and Schmitt, J. 1989. Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol, 25, 50–5.CrossRef Google Scholar PubMed

Davis, L. and Sperry, S. 1978. Bell’s palsy and secondary syphilis: CSF spirochetes detected by immunofluorescence. Ann Neurol, 4, 378–80.Google Scholar

Duncan, P. W., Zorowitz, R., Bates, B., et al. 2005. Management of adult stroke rehabilitation care: A clinical practice guideline. Stroke, 36, e100–43.CrossRef Google Scholar

Farhi, D. and Dupin, N. 2010. Origins of syphilis and management of the immunocompetent patient: Facts and controversies. Clin Derm, 28, 533–8.Google Scholar

Fisher, M. and Poser, C. M. 1977. Syphilitic meningomyelitis: A case report. Arch Neurol, 34, 785.Google Scholar

Flint, A. C., Liberato, B. B., Anziska, Y., Schantz-Dunn, J., and Wright, C. B. 2005. Meningovascular syphilis as a cause of basilar artery stenosis. Neurology, 64, 391–2.Google Scholar

Funnye, A. S. and Akhtar, A. J. 2003. Syphilis and human immunodeficiency virus co-infection. J Natl Med Assoc, 95, 363–82.Google Scholar PubMed

Gaa, J., Weidauer, S., Sitzer, M., Lanfermann, H., and Zanella, F. E. 2004. Cerebral vasculitis due to Treponema pallidum infection: MRI and MRA findings. Eur Radiol, 14, 746–7.Google Scholar

Gallego, J., Soriano, G., Zubieta, J. L., Delgado, G., and Villanueva, J. A. 1994. Magnetic resonance angiography in meningovascular syphilis. Neuroradiology, 36, 208–9.CrossRef Google Scholar PubMed

Gjestland, T. 1955. The Oslo study of untreated syphilis: An epidemiologic investigation of the natural course of syphilis infection based upon restudy of the Boeck–Bruusgaard material. Acta Derm Venereol, 35, 3–368, Annex I–LVI.Google Scholar

Golden, M. R., Marra, C. M., and Holmes, K. K. 2003. Update on syphilis: Resurgence of an old problem. JAMA, 290, 1510–4.Google Scholar

Good, C. D., and Jager, H. R. 2000. Contrast enhancement of the cerebrospinal fluid on MRI in two cases of spirochaetal meningitis. Neuroradiology, 42, 448–50.CrossRef Google Scholar PubMed

Gray, F. and Alonso, J. M. 2002. Bacterial infections of the central nervous system. In Greenfield’s Neuropathology, 7th edn., Graham, D. I. and Lantos, P. L., eds. London: Arnold, pp. II:178–II:184.Google Scholar

Harrigan, E. P., McLaughlin, T. J., and Feldman, R. G. 1984. Transverse myelitis due to meningovascular syphilis. Arch Neurol, 41, 337–8.Google Scholar

Holland, B. A., Perrett, L. V., and Mills, C. M. 1986. Meningovascular syphilis: CT and MRI findings. Radiology, 158, 439–42.Google Scholar

Hook, E. W. III, and Peeling, R. W. 2004. Syphilis control: A continuing challenge. N Engl J Med, 351, 122–4.CrossRef Google Scholar PubMed

Hooshmand, H., Escobar, M. R., and Kopf, S. W. 1972. Neurosyphilis. A study of 241 patients. JAMA, 219, 726–9.CrossRef Google Scholar PubMed

Hotson, J. R. 1981. Modern neurosyphilis: A partially treated chronic meningitis. West J Med, 135, 191–200.Google Scholar PubMed

Jay, C. A. 2006. Treatment of neurosyphilis. Curr Treat Options Neurol, 8, 185–92.Google Scholar

Jenier, M., Hegyi, V., Dupin, N., et al. 2014. 2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol, 28, 1581–93.CrossRef Google Scholar

Johns, D. R., Tierney, M., and Parker, S. W. 1987. Pure motor hemiplegia due to meningovascular neurosyphilis. Arch Neurol, 44, 1062–5.Google Scholar

Kelley, R. E., Bell, L., Kelley, S. E., and Lee, S. C. 1989. Syphilis detection in cerebrovascular disease. Stroke, 20, 230–4.Google Scholar

Kelley, R. E., Minagar, A., Kelley, B. J., and Brunson, R. 2003. Transcranial Doppler monitoring of response to therapy for meningovascular syphilis. J Neuroimaging, 13, 85–7.Google Scholar

Kierland, R. R., O’Leary, P. A., and Vandoren, E. 1942. Symptomatic neurosyphilis. J Vener Dis Inf, 22, 360–77.Google Scholar

LaFond, R. E, Lukehart, S. A. 2006. Biological basis for syphilis. Clin Microbiol Rev, 19, 29–49.Google Scholar

Landi, G., Villani, F., and Anzalone, N. 1990. Variable angiographic findings in patients with stroke and neurosyphilis. Stroke, 21, 333–8.CrossRef Google Scholar PubMed

Liu, L. L., Zheng, W. H., Tong, M. L., et al. 2012. Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. J Neurol Sci, 317, 35–9.CrossRef Google Scholar PubMed

Lowenstein, D. H., Mills, C., and Simon, R. P. 1987. Acute syphilitic transverse myelitis: Unusual presentation of meningovascular syphilis. Genitourin Med, 63, 333–8.Google Scholar

Lukehart, S. A., Hook, E. W. III, Baker-Zander, S. A., et al. 1988. Invasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment. Ann Intern Med, 109, 855–62.Google Scholar

Lukehart, S. A., Godornes, C., Molini, B. J., et al. 2004. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med, 351, 154–8.Google Scholar

Marra, C. M. 2004. Neurosyphilis. In Infections of the Central Nervous System, 3rd edn. Philadelphia: Lippincott, Williams & Wilkins, pp. 649–57.Google Scholar

Marra, C. M. 2015. Neurosyphilis. Continuum (Minneap Minn), 21, 1714–28.Google Scholar PubMed

Marra, C. M., Maxwell, C. L., Smith, S. L., et al. 2004a. Cerebrospinal fluid abnormalities in patients with syphilis: Association with clinical and laboratory features. J Infect Dis, 189, 369–76.CrossRef Google Scholar PubMed

Marra, C. M., Maxwell, C. L., Tantalo, L., et al. 2004b. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: Does HIV status matter? Clin Infect Dis, 38, 1001–6.CrossRef Google Scholar PubMed

Merritt, H. H., Adams, R. D., and Solomon, H. C. 1946. Neurosyphilis. New York: Oxford University Press, pp. 83–174.Google Scholar

Merritt, H. H. and Moore, M. 1935. Acute syphilitic meningitis. Medicine, 14, 119–83.Google Scholar

Moore, J. 1941. The Modern Treatment of Syphilis, 2nd edn., Springfield: CC Thomas.Google Scholar

Nabatame, H., Nakamura, K., Matuda, M., et al. 1992. MRI of syphilitic myelitis. Neuroradiology, 34, 105–6.Google Scholar

Noordhoek, G. T., Engelkens, H. J., Judanarso, J., et al. 1991. Yaws in West Sumatra, Indonesia: Clinical manifestations, serological findings and characterization of new Treponema isolates by DNA probes. Eur J Clin Microbiol Infect Dis, 10, 12–9.Google Scholar

Nordenbo, A. M., and Sorensen, P. S. 1981. The incidence and clinical presentation of neurosyphilis in Greater Copenhagen, 1974 through 1978. Acta Neurol Scand, 63, 237–46.Google Scholar

Peng, F., Hu, X., Zhong, X., et al. 2008. CT and MR findings in HIV-negative neurosyphilis. Eur J Radiol, 66, 1–6.CrossRef Google Scholar

Perdrup, A., Jorgensen, B. B., and Pedersen, N. S. 1981. The profile of neurosyphilis in Denmark. A clinical and serological study of all patients in Denmark with neurosyphilis disclosed in the years 1971–1979 incl. by Wassermann reaction (CWRM) in the cerebrospinal fluid. Acta Derm Venereol Suppl (Stockh), 96, 1–14.Google Scholar

Peterman, T., Heffelfinger, J., Swint, E., and Groseclose, S. 2005. The changing epidemiology of syphilis. Sex Transm Dis, 32, S4–S10.Google Scholar

Peters, K. M., Adam, G., Biedermann, M., Zilkens, K. W., and Gunther, R. 1993. Osteomyelitis today: Diagnostic imaging and therapy. Zentralbl Chir, 118, 637–45.Google Scholar

San Francisco Department of Public Health. 2005. San Francisco Sexually Transmitted Disease Annual Summary, 2004.Google Scholar

Shockman, S., Buescher, L. S., Stone, S. P. 2014. Syphilis in the United States. Clin Derm, 32, 213–8.Google Scholar

Silber, M. H. 1989. Syphilitic myelopathy. Genitourin Med, 65, 338–41.Google Scholar PubMed

Simon, R. P. 1985. Neurosyphilis. Arch Neurol, 42, 606–13.Google Scholar

Timmermans, M. and Carr, J. 2004. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry, 75, 1727–30.Google Scholar

Tyler, K. L., Sandberg, E., and Baum, K. F. 1994. Medical medullary syndrome and meningovascular syphilis: A case report in an HIV-infected man and a review of the literature. Neurology, 44, 2231–5.Google Scholar

Umashankar, G., Gupta, V., and Harik, S. I. 2004. Acute bilateral inferior cerebellar infarction in a patient with neurosyphilis. Arch Neurol, 61, 953–6.Google Scholar

Vartdal, F., Vandvik, B., Michaelsen, T. E., Loe, K., and Norrby, E. 1982. Neurosyphilis: Intrathecal synthesis of oligoclonal antibodies to Treponema pallidum. Ann Neurol, 11, 35–40.Google Scholar

Vatz, K. A., Scheibel, R. L., Keiffer, S. A., and Ansari, K. A. 1974. Neurosyphilis and diffuse cerebral angiopathy: A case report. Neurology, 24, 472–6.Google Scholar

Winstein, C. J., Stein, J., Arena, R., et al. Guidelines for adult stroke rehabilitation and recovery: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. 2016. Stroke, 47, e98–169.Google Scholar

Wong, T., Fonesca, K., Chernesky, M.A., et al. 2015. Canadian Public Health Laboratory Network laboratory guidelines for the diagnosis of neurosyphilis in Canada. Can J Infect Dis Med Microbiol, 26 (suppl A), 18A–22A.Google Scholar

References

Akalin, H., Akdis, A. C., and Mistik, R., et al. 1994. Cerebrospinal fluid interleukin-beta/interleukin-I receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. Scand J Infect Dis, 26, 667–74.Google Scholar

Andronikou, S., Wilmshurst, J., Hatherill, M., and VanToorn, R. 2006. Distribution of brain infarction in children with tuberculous meningitis and correlation with outcome score at 6 months. Pediatr Radiol, 36, 1289–94.Google Scholar

Askanazy, M. 1910. (Quoted by Winkleman, N. W., and Moore, T. 1940. Meningeal blood vessels in tuberculous meningitis. Am Rev Tuberc, 42, 315–33).Google Scholar

Babu, G. N., Kumar, A., Kalita, J., and Misra, U. K. 2008. Proinflammatory cytokine levels in the serums and cerebrospinal fluid of tuberculous meningitis patients. Neurosc Lett, 436, 48–51.Google Scholar

Baumgarten, P. 1881. Gammose arteritis und entsprechende tuberculose veranderungen. Virchows Arch Pathol Anat Physiol Klin Med, 179, 86.Google Scholar

Berenguer, J., Moreno, S., Laguna, F. et al. 1992. Tuberculous meningitis in patients infected with the human immunodeficiency virus infection. N Engl J Med, 326, 668–72.Google Scholar

Brancusi, F., Farrar, J., and Heemskerk, D. 2012. Tuberculous meningitis in adults: A review of a decade of developments focusing on prognostic factors for outcome. Future Microbiol, 7, 1101–16.Google Scholar

Chen, P., Shi, M., Feng, G. D., et al. 2012. A highly efficient Ziehl–Neelsen stain: Identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin Microbiol, 50, 1166–70.Google Scholar

Collomb, H., Lemercier, G., Virieu, R., and Dumas, M. 1967. Multiple cerebral vascular thrombosis due to arteritis associated with tuberculous meningitis. Bulletin Societé Medecale d’Afriqu Noire de Langue Français, 12, 813–22.Google Scholar

Cotran, R. S., Kumar, V., and Collins, T. 1999. Diseases of immunity. In Robbins Pathological Basis of Disease, eds. Cotran, R. S., Kumar, V., and Collins., T. Philadelphia: W. B. Saunders, pp. 188–259.Google Scholar

Crithchley, J. A., Young, F., Orton, L., and Gamer, P. 2013. Corticosteroids for prevention of mortality in people with tuberculosis: A systemic review and meta-analysis. The Lancet, 13, 223–37.Google Scholar

Dalal, P. M. 1979. Observations on the involvement of cerebral vessels in tuberculous meningitis in adults. In Advances in Neurology, eds. Goldstein, M., Bolis, L., Fieschi, C., Gorini, S., and Millikan, C. H.. New York: Raven Press, vol. 25, pp. 149–59.Google Scholar

Dalal, P. M. and Dalal, K. P. 1989. Cerebrovascular manifestations of infectious disease. In Toole, J. F.., ed. Handbook of Clinical Neurology. Amsterdam: Elsevier, vol. 11, pp. 411–41.Google Scholar

Dastur, D. K. and Lalitha, V. S. 1973. The many facets of neurotuberculosis: An epitome of neuropathology. In Progress in Neuropathology, ed. Zimmerman, H.. New York: Grune and Stratton, pp. 351–408.Google Scholar

Dastur, D. K., Lalitha, V. S., Udani, P. M., and Parekh, U. 1970. The brain and meninges in TBM. Gross pathology and pathogenesis in 100 cases. Neurol India, 18, 86–100.Google Scholar

Denkinger, C. M., Schumacher, S. G., Boehme, C. C., et al. 2014. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: systematic review and meta-analysis. Eur Respir J, 44, 435–46.Google Scholar

Deshpande, D. H., Bharucha, E. P., and Mondkar, V. P. 1969. Tuberculous meningitis in adults. Neurol India, 17, 28–35.Google Scholar PubMed

Donald, P. R., Schoeman, J. F., Beyers, N., et al. 1995. Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-I beta in the cerebrospinal fluid of children treated for tuberculous meningitis. Clin Infect Dis, 21, 924–9.Google Scholar

Dube, M. P., Holton, P. D., and Larsen, R. A. 1992. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med, 93, 520–4.Google Scholar

Hsieh, F., Chia, L., and Shen, W. 1992. Location of cerebral infarctions in tuberculous meningitis. Neuroradiology, 34, 197–9.Google Scholar

Kalita, J., Misra, U. K., and Nair, P. P. 2009. Predictors of stroke and its significance in the outcome of tuberculous meningitis. J Stroke Cerebrovasc Dis, 18, 251–58.Google Scholar

Kalita, J., Prasad, S., Maurya, P. K., Kumar, S., and Misra, U. K. 2012. MR angiography in tuberculous meningitis. Acta Radiol, 53, 324–29.Google Scholar

Katrak, S. M., Shembalkar, P. K., Bijwe, S. R., and Bhandarkar, L. D. 2000. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci, 181, 118–26.Google Scholar

Kawre, K. K., Satishchandra, P., Shankar, S. K., et al. 2001. Tuberculous meningitis with and without HIV infection. Abstracts of Annual Conference of Neurological Society of India, A225, 311–2.Google Scholar

Kingsley, D. P. E., Hendrickse, W. A., Kendall, B. E., et al. 1987. Tuberculous meningitis: Role of CT in management and prognosis. J Neurol Neurosurg Psychiatry, 50, 30–6.Google Scholar

Lammie, G. A., Hewlett, R. H., Schoeman, J. F., and Donald, P.R., 2009. Tuberculous cerebrovascular disease: A review. J Infect, 59, 156–66.Google Scholar

Lan, S. H., Chang, W. N., Lu, C. H., Lui, C. C., and Chang, H. W. 2001. Cerebral infarction in chronic meningitis: A comparison of tuberculous meningitis and cryptococcal meningitis. Q J Med, 94, 247–53.Google Scholar

Lehrer, H. 1966. The angiographic triad in tuberculous meningitis. Radiology, 87, 829.Google Scholar

Mastroianni, C. M., Paoletti, F., Lichtner, M., D’Agostino, C., et al. 1997. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin Immunol Immunopathol, 84, 171–6.Google Scholar

Mishra, N. K. and Goyal, M. 1999. Imaging of CNS Tuberculosis in Neurology in Tropics, eds. Chopra, J. S., and Sawhney, I. M. S.. New Delhi: BI Churchill Livingstone Pvt. Ltd, pp. 370–90.Google Scholar

Misra, U. K., Kalita, J., and Maurya, P. K. 2011. Stroke in tuberculous meningitis. J Neurol Sci, 303, 22–30.Google Scholar

Morse, D. 1961. Prehistoric TB in America. Am Rev Respir Dis, 83, 489.Google Scholar

Patel, V. B., Bhigjee, A. I., Bill, P. L. A., and Connolly, C. A. 2002. Cytokine profile in HIV seropositive patients with tuberculous meningitis. J Neurol Neurosurg Psychiatry, 73, 598–9.Google Scholar

Pienaar, M., Andronikou, S., and van Toorn, R. 2009. MRI to demonstrate diagnostic features and complications of TBM not seen with CT. Childs Nerv Syst, 25, 941–7.CrossRef Google Scholar

Poltera, A. A. 1977. Thrombogenic intracranial vasculitis in tuberculous meningitis. A 20 year post mortem survey. Acta Neurol Belg, 77, 112–24.Google Scholar

Porkert, M. T., Sotir, M., Parrott-Moore, P., and Blumberg, H. M. 1997. Tuberculous meningitis at a large inner city medical centre. Am J Med Sci, 313, 325–31.Google Scholar

Prasad, K., Singh, M. B., and Ryan, H. 2016. Corticosteroids for managing tuberculous meningitis. Cochrane Database System Rev, 4, 1–64.Google Scholar

Rich, A. R. and McCordock, H. A. 1933. The pathogenesis of tuberculous meningitis. Bull Johns Hopkins Hosp, 53, 5–37.Google Scholar

Rojas-Echeverri, L. A., Soto-Hernandez, J. L., and Garza, S., et al. 1996. Predictive value of digital subtraction angiography in patients with tuberculous meningitis. Neuroradiology, 38, 20–24.Google Scholar

Shankar, S. K. 1989. CNS vasculopathy–revisited. In Progress in Clinical Neurosciences 5, eds. Sinha, K. K. and Chandra, P.. Ranchi: Neurological Society of India, Catholic Press, pp. 93–101.Google Scholar

Shukla, R., Abbas, A., Kumar, P., Gupta, R. K., et al. 2008. Evaluation of cerebral infarction in tuberculous meningitis by diffusion weighted imaging. J Infect, 57, 298–306.Google Scholar

Simmons, C. P., Thwaites, G. E., Quyen, N. T. et al., 2005. The clinical benefit of adjunctive dexamethasone in the tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses J Immunol, 175, 579–90.Google Scholar

Singhal, B. S., Bhagwati, S. N., Sayed, A. H., and Laud, G. W. 1975. Raised intracranial pressure in tuberculous meningitis. Neurol India, 23, 32–9.Google Scholar

Sinha, H. P., Modi, M., Prabhakar, S., and Singh, P. 2015. Do cytokines correlate with disease activity in tuberculous meningitis? Neurology Asia, 20, 243–50.Google Scholar

Streptomycin in Tuberculosis Trial Committee. 1948. Medical Research Council streptomycin treatment of tuberculous meningitis. Lancet, 1, 582–96.Google Scholar

Sze, G. and Zimmerman, R. D. 1988. The magnetic resonance imaging of infections and inflammatory diseases. Radiol Clin North Am, 26, 839–59.CrossRef Google Scholar PubMed

Takahashi, T., Nakayama, T., and Tamura, M., et al. 2005. Nested polymerase chain reaction for assessing the clinical cause of tuberculous meningitis. Neurology, 64, 1789–93.Google Scholar

Thomas, M. D., Chopra, J. S., Banerjee, A. K., and Singh, M. S. 1997. Tuberculous meningitis: A clinicopathological study. Neurol India, 25, 26–34.Google Scholar

Thwaites, G. E., Bang, N. D., Dung, N. H., et al. 2004. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med, 351, 1741–51.Google Scholar

Thwaites, G. E., Macmullen-Price, J., Chau, T. T. H., and Mal, P. P., et al. 2007. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: An observational study. Lancet Neurol, 6, 282–90.Google Scholar

Thwaites, G. E., Bhavnani, S. M., and Chau, T. T., et al. 2011. Randomized pharmacokinetic and pharmacodynamics comparison of fluoroquinolones for tuberculous meningitis. Antimicrob Agents Chemother, 55, 3244–53.Google Scholar

Udani, P. M., Parekh, U. C., and Dastur, D. K. 1971. Neurological and related syndromes in CNS tuberculosis: Clinical features and pathogenesis. J Neurol Sci, 14, 341–57.Google Scholar

Vashishta, R. K. and Banerjee, A. K. 1999. CNS Tuberculosis – Pathology. In Neurology in Tropics, eds. Chopra, J. S., and Sawhney, I. M. S.. New Delhi: BI Churchill Livingstone Pvt. Ltd, pp. 391–8.Google Scholar

Villora, M. F., Fortea, F., Moreno, S., et al. 1995. MR imaging and CT of central nervous system tuberculosis in patients with AIDS. Radiol Clin North Am, 33, 805–20.Google Scholar

Wadia, N. H. and Singhal, B. S. 1967. Cerebral arteriography in tuberculous meningitis. Neurol India, 25, 127–32.Google Scholar

Winkleman, N. W. and Moore, T. 1940. Meningeal blood vessels in tuberculous meningitis. Am Rev Tuberc, 42, 315–33.Google Scholar

WHO, 2014. Global Tuberculosis Report 2014. Geneva: World Health Organization.Google Scholar

Yamashima, T., Kashihara, K., Ikeda, K., Kubota, T., and Yamamoto, S. 1985. Three phases of cerebral arteriopathy in meningitis: Vasospasm and vasodilatation followed by organic stenosis. Neurosurgery, 16, 546–53.Google Scholar

Yechoor, V. K., Shandera, W. X., Rodriguez, P., and Cate, T. R. 1990. Tuberculous meningitis among adults with or without HIV infection. Arch Intern Med, 156, 1710–6.Google Scholar

References

Antinori, S., Corbellino, M., Meroni, L., et al. 2013. Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infection, 66, 218–38.CrossRef Google Scholar PubMed

Arsura, E. L., Johnson, R., Penrose, J., et al. 2005. Neuroimaging as a guide to predict outcomes for patients with coccidioidal meningitis. Clin Inf Dis, 40, 624–27.CrossRef Google Scholar PubMed

Asari, S., Nishimoto, A., and Murakami, M. 1988. A rare case of cerebral Aspergillus aneurysm at the site of the temporary clip application. No Shinkie Geka, 16, 1079–82.Google Scholar

Baddley, J. W., Salzman, D., and Pappas, P. G. 2002. Fungal brain abscess in transplant recipients: Epidemiologic, microbiologic, and clinical features. Clin Transplant, 16, 419–24.Google Scholar

Bariola, J. R., Perry, P., Pappas, P. G., et al. 2010. Blastomycosis of the central nervous system: A multicenter review of diagnosis and treatment in the modern era. Clin Inf Dis, 50, 797–804.Google Scholar

Beal, M. F., O’Carroll, C. P., Kleinman, G. M., and Grossman, R. I. 1982. Aspergillosis of the central nervous system. Neurology, 32, 473–9.Google Scholar

Bodey, G., Bueltman, B., Duguid, W., et al. 1992. Fungal infections in cancer patients: An international autopsy survey. Eur J Clin Microbiol Infect Dis, 11, 99–109.CrossRef Google Scholar PubMed

Boes, B., Bashir, R., Boes, C., et al. 1994. Central nervous system aspergillosis: Analysis of 26 cases. J Neuroimaging, 4, 123–9.Google Scholar

Bor, D. H., Woolhandler, S., Nardin, R., Brusch, J., and Himmelstein, D. U. 2013. Infective endocarditis in the U.S., 1998–2009: A nationwide study. PLoS One, 8, e60033.Google Scholar

Breadmore, R., Desmond, P., and Opeskin, K. 1994. Intracranial aspergillosis producing cavernous sinus syndrome and rupture of the internal carotid artery. Australas Radiol, 38, 795–7.Google Scholar

Burgert, S. J., Classen, D. C., Burke, J. P., and Blatter, D. D. 1995. Candidal brain abscess associated with vascular invasion: A devastating complication of vascular catheter-related candidemia. Clin Inf Dis, 21, 202–5.Google Scholar

Cachia, D., Singh, C., Tetzlaff, M.T., Penas-Prado, M. 2015. Middle cerebral artery territory infarct due to cryptococcus infections: An uncommon indication for cerebrospinal fluid analysis in stroke patients. Diagn Cytopath, 43, 632–4.Google Scholar

Cimbaluk, D., Scudiere, J., Butsch, J., and Jakate, S. 2005. Invasive candidal enterocolitis followed shortly by fatal cerebral hemorrhage in immunocompromised patients. J Clin Gastroenterol, 39, 795–7.Google Scholar

Cleri, D. J., Moser, R. L., Viollota, F. J., et al. 2003. Pulmonary aspergillosis and central nervous system hemorrhage as complications of hemolytic anemia treated with corticosteroids. South Med J, 96, 592–5.Google Scholar

Coplin, W. M., Cochran, M. S., Levine, S. R., and Crawford, S. W. 2001. Stroke after bone marrow transplantation: Frequency, aetiology and outcome. Brain, 124, 1043–51.Google Scholar

Corvisier, N., Gray, F., Cherardi, R., et al. 1987. Aspergillosis of ethmoid sinus and optic nerve, with arteritis and rupture of the internal carotid artery. Surg Neurol, 28, 311–5.Google Scholar

de Almeida, S. M., Querioz-Telles, F., Tieve, H. A., Ribeiro, C. E., and Wernek, L. C. 2004. Central nervous system paracoccidiomycosis: clinical features and laboratorial findings. J Infect, 48, 193–8.Google Scholar

de Medeiros, C. R., Bleggi-Torre, L. F., Faoro, L. N., et al. 2001. Cavernous sinus thrombosis caused by zygomycosis after unrelated bone marrow transplantation. Transplant Infectious Diseases, 3, 231–4.Google Scholar

de Pauw, B. D. E. and Meunier, F. 1999. The challenge of invasive fungal infections. Chemotherapy, 45(suppl.), 1–14.Google Scholar

Dooley, D. P., Hollsten, D. A., Grimes, S. R., and Moss, J. Jr. 1992. Indolent orbital apex syndrome caused by occult mucormycosis. J Clin Neuroophthalmol, 12, 245–9.Google Scholar

Ebright, J. R., Pace, M. T., and Niazi, A. F. 2001. Septic thrombosis of the cavernous sinuses. Arch Intern Med, 161, 2671–6.Google Scholar

Endo, T., Tominaga, T., Konno, H., and Yoshimoto, T. 2002. Fatal subarachnoid hemorrhage, brainstem and cerebellar infarction, caused by aspergillus infection after cerebral aneurysm surgery: Case report. Neurosurgery, 50, 1147–51.Google Scholar

Ermak, D., Kanekar, S., Specht, C. S., Wojnar, M., and Lowden, M. 2014. Looks like a stroke, acts like a stroke, but it’s more than a stroke: A case of cerebral mucormycosis. J Stroke Cerebrovasc Dis, 23, e403–4.Google Scholar

Eucker, J., Sezer, O., Graf, B., and Possinger, K. 2001. Mucormycoses. Mycoses, 44, 253–60.Google Scholar

Fu, K. A., Nguyen, P. L., and Sanossian, N. 2015. Basilar artery territory stroke secondary to invasive fungal sphenoid sinusitis: A case report. Case Rep Neurol, 7, 51–8.Google Scholar

Gabelmann, A., Klein, S., Kern, W., et al. 2007. Relevant imaging findings of cerebral aspergillosis on MRI: A retrospective case-based study in immunocompromised patients. Eur J Neurol, 14, 548–55.Google Scholar

Germain, M., Gourdeau, M., and Hebert, J. 1994. Case report: Familial chronic mucocutaneous candidiasis complicated by deep candida infection. Am J Med Sci, 307, 282–3.Google Scholar

Girishkumar, H., Yousuf, A. M., Ghivate, J., and Geisler, E. 1999. Experience with invasive candida infections. Postgrad Med J, 75, 151–2.CrossRef Google Scholar PubMed

Gollard, R., Rabb, C., Larsen, R., and Chandrasoma, P. 1994. Isolated cerebral mucormycosis: Case report and therapeutic considerations. Neurosurgery, 34, 174–7.Google Scholar

Gonzalez-Duarte, A., Calleja, J. H., Mitre, V. G., and Ramos, G. G. 2009. Simultaneous central nervous system complications of C. neoformans infection. Neurology Intl, 1, 82–3.Google Scholar

Grouhi, M., Ilan, D., Misbet-Brown, E., and Roifman, C. M., 1998. Cerebral vasculitis associated with chronic mucocutaneous candidiasis. J Pediatr, 133, 571–4.Google Scholar

Hall, W. A. and Nussbaum, E. S. 1995. Isolated cerebral mucormycosis: Case report and therapeutic considerations [correspondence]. Neurosurgery, 36, 623.Google Scholar

Haran, R. P., Chandy, M. J. 1993. Intracranial aspergillus granuloma. Br J Neurosurg, 7, 383–88.Google Scholar

Ihara, K., Makita, Y., Nabeshima, S., Tei, T., Keyaki, A., and Kioka, H. 1990. Aspergillosis of the central nervous system causing subarachnoid hemorrhage from mycotic aneurysm of the basilar artery: Case report. Neurol Med Chir, 30, 618–23.Google Scholar

Kameh, D. S. and Gonzalez, O. R. 1997. Fatal rhino-orbital-cerebral zygomycosis. South Med J, 90, 1133–7.Google Scholar

Khan, M. U., Ali, S., Baig, M. A., et al. 2007. Candida parapsilosis endocarditis 8 months after transient candidemia. Int J Cardiol, 118, e58–e59.CrossRef Google Scholar PubMed

Kieburtz, K. D., Eskin, T. A., Ketonen, T. A., and Tuite, M. J. 1993. Opportunistic cerebral vasculopathy and stroke in patients with acquired immunodeficiency syndrome. Arch Neurol, 50, 430–2.Google Scholar

Kleinschmidt-DeMasters, B. K. 2002. Central nervous system aspergillosis: A 20-year retrospective series. Hum Pathol, 33, 116–24.Google Scholar

Koc, Z., Koc, F., Yerdelen, D., and Ozdogu, H. 2007. Rhino-orbital-cerebral mucormycosis with different cerebral involvements: Infarct, hemorrhage, and ophthalmoplegia. Int J Neurosci, 117, 1677–90.Google Scholar

Lan, S. H., Chang, W. N., Lu, C. H., Liu, C. C., and Chang, H.W. 2001. Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis. Q J Med, 94, 247–53.Google Scholar

Lass-Florl, C. D., Griff, K., Mayr, A., et al. 2005. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol, 312, 201–7.Google Scholar

Lau, A. H., Takeshita, M., and Ishii, N. 1991. Mycotic (aspergillus) arteritis resulting in fatal subarachnoid hemorrhage: A case report. Angiology, 42, 251–5.Google Scholar

Li, C. S., Huang, C. R., Lu, C. H., Lui, C. C., Chien, C. C., and Chang, W. N. 2004. Concomitant stroke and candida parapsilosis native valve endocarditis: report of one case and literature review. Acta Neurol Taiwan, 13, 131–5.Google Scholar

Lipton, S. A., Hickey, S. F., Morris, J. H., and Loscalzo, J. 1984. Candidal infection in the central nervous system. Am J Med, 76, 101–8.Google Scholar

Liu, Z. Y., Sheng, R. Y., Li, D. L., Li, T. S., and Wang, A. X. 2003. Nosocomial fungal infections, analysis of 149 cases. Zhonghua Yi Xue Za Zhi, 83, 399–403.Google Scholar

Mathur, S. C., Friedman, H. D., Kende, A. J., Davis, R. L., and Graziano, S. L. 1999. Cryptic mucor infection leading to massive cerebral infarction at initiation of antileukemic chemotherapy. Ann Hematol, 78, 241–5.Google Scholar

Matsumura, S., Sato, S., Fujiwara, H., et al. 1988. Cerebral aspergillosis as a cerebrovascular accident. Brain Nerve, 40, 225–32.Google Scholar

Munksgaard, B. 2004. Fungal infections. Am J Transplant, 4 (suppl. 10), 110–34.Google Scholar

Munoz, J., Hughes, A., and Guo, Y. 2013. Mucormycosis-associated intracranial hemorrhage. Blood Coag and Fibrinolysis, 24, 100–1.Google Scholar

Murthy, J. M., Sundaram, C., Prasad, V. S., et al. 2000. Aspergillosis of the central nervous system: A study of 21 patients seen in a university hospital in south India. J Assoc Physicians India, 48, 677–81.Google Scholar

Nguyen, F. N., Kar, J. K., Zakaria, A., and Schiess, M. C. 2013. Isolated central nervous system histoplasmosis presenting with ischemic pontine stroke and meningitis in an immune-competent patient. JAMA Neurol, 70, 638–41.Google Scholar

Oner, A. Y., Celik, H., Akpek, S., and Tokgoz, N. 2006. Central nervous system aspergillosis: Magnetic resonance imaging, diffusion-weighted imaging, and magnetic resonance spectroscopy features. Acta Radiologica, 47, 408–12.Google Scholar

Pagano, L., Ricci, P., Montillo, M., et al. 1996. Localization of aspergillosis to the central nervous system among patients with acute leukemia: A report of 14 cases. Gruppo Italiano Malattie Ematologiche dell’Adulto Infection Program. Clin Infect Dis, 23, 628–30.Google Scholar

Parker, J. C., McCloskey, J. J., and Lee, R.S. 1981. Human cerebral candidosis: A postmoretem analysis of 19 patients. Human Path, 12, 23–8.Google Scholar

Piotrowski, W. P. and Pilz, P. 1994. Postoperative fungal arteritis mimicking vasospasm. Neurol Medic Chir, 34, 315–8.Google Scholar

Rangel-Guerra, R., Martinez, H. R., Saenz, C. Bosques-Padilla, F., and Estrada-Bellman, I. 1996. Rhinocerebral and system mycormycosis. Clinical experience with 36 cases. J Neurol Sci, 143, 19–30.Google Scholar

Roger, P. M., Boissy, C., Gari-Toussaint, M., et al. 2000. Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrate. J Inf, 41, 176–8.Google Scholar

Rogers, L. R. 2003. Cerebrovascular complications in cancer patients. Neurol Clin, 21, 167–92.Google Scholar

Rosario, M., Song, S. X., and McCullough, L. D. 2012. An unusual case of stroke. Neurologist, 18, 229–32.Google Scholar

Saul, R. F., Gallagher, J. G., and Mateer, J.E. 1986. Sudden hemiparesis as the presenting sign in cryptococcal meningoencephalitis. Stroke, 17, 753–4.Google Scholar

Scharf, E. L., Cloft, H. J., and Wijdicks, E. 2016. Mucor thrombus. Neurocrit Care, 24, 268–72.Google Scholar

Smith, R. M., Schaefer, M. K., Kainer, M. A., et al. 2013. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med, 369, 1598–609.Google Scholar

Sun, X. L., Zhang, J., Wang, G. G, et al. 2013 Comparison of characteristics and short-term outcome from fungal infective endocarditis in prosthetic valve endocarditis versus native valve endocarditis. Am J Cardiol, 112, 111–6.Google Scholar

Sundaram, C., Mahadevan, A., Laxmi, V. et al. 2005. Cerebral zygomycosis. Mycoses, 48, 396–407.Google Scholar

Suzuki, K., Iwabuchi, N., Kuramochi, S. et al. 1995. Aspergillus aneurysm of the middle cerebral artery causing a fatal subarachnoid hemorrhage. Intern Med, 34, 550–3.Google Scholar

Takahashi, Y., Sugita, Y., Maruiwa, H., et al. 1998. Fatal hemorrhage from rupture of the intracranial internal carotid artery caused by aspergillus arteritis. Neurosurg Rev, 21, 198–201.Google Scholar

Terol, J. J., Tassies, D., Lopez-Guillermon, A., et al. 1994. Sepsis by Candida tropicalis in patients with granulocytopenia: A study of 10 cases. Med Clin (Barc), 103, 579–82.Google Scholar

Torres-Cisneros, J., Lopez, O. L., Kusne, S., et al. 1993. CNS aspergillosis in organ transplantation: A clinicopathologic study. J Neurol, Neurosurg, Psychiatry, 56, 188–93.Google Scholar

Verma, A., Brozman, B., and Petito, C. K. 2005. Isolated cerebral mucormycosis: Report of a case and review of the literature. J Neurol Sci, 240, 65–9.Google Scholar

Vilchez, R. A., Fung, J., and Kusne, S. 2002. Cryptococcosis in organ transplant recipients: An overview. Am J Transplant, 2, 576–80.Google Scholar

Walshe, T. J., Hier, D. B., and Caplan, L. R. 1985a. Aspergillosis of the central nervous system: Clinicopathological analysis of 17 patients. Ann Neurol, 18, 574–82.Google Scholar

Walshe, T. J., Hier, D. B., and Caplan, L. R. 1985b. Fungal infections of the central nervous system: Comparative analysis of risk factors and clinical signs. Neurology, 35, 1654–7.Google Scholar

Zalduondo, F. M., Provenzale, J. M., Hulette, C., and Gorecki, J. P. 1996. Meningitis, vasculitis, and cerebritis caused by CNS histoplasmosis: Radiologic–pathologic correlation. Am J Radiol, 166, 194–6.Google Scholar

Zhang, R., Zhang, J. W., and Szerlip, H. M. 2002. Endocarditis and hemorrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am J Kidney Dis, 40, 842–6.Google Scholar

References

Aditya, G. S., Mahadevan, A., Santosh, V., et al. 2004. Cysticercal chronic basal arachnoiditis with infarcts, mimicking tuberculous pathology in endemic areas. Neuropathology, 24, 320–5.Google Scholar

Alarcón, F., Hidalgo, F., Moncayo, J., Viñán, I., and Dueñas, G. 1992a. Cerebral cysticercosis and stroke. Stroke, 23, 224–8.Google Scholar

Alarcón, F., Vanormelingen, K., Moncayo, J., and Viñán, I. 1992b. Cerebral cysticercosis as a risk factor for stroke in young and middle-aged people. Stroke, 23, 1563–5.Google Scholar

Arteaga-Rodríguez, C., Naréssi-Munhoz, A. H., and Hernández-Fustes, O. J. 2004. Infarto cerebral extenso y neurocisticercosis. Rev Neurol, 39, 583.Google Scholar

Asenjo, A. 1950. Setenta y dos casos de cisticercosis en el instituto de neurocirugía. Revista de Neuro-Psiquiatría, 13, 337–53.Google Scholar

Bang, O. Y., Heo, J. H., Choi, S. A., and Kim, D. I. 1997. Large cerebral infarction during praziquantel therapy in neurocysticercosis. Stroke, 28, 211–3.Google Scholar

Barinagarrementería, F. 1989. Causas no aterosclerosas de isquemia cerebral. Arch Inst Nac Neurol Neurocir Mex, 4 (suppl), 33.Google Scholar

Barinagarrementería, F. and Cantú, C. 1992. Neurocysticercosis as a cause of stroke. Stroke, 23, 1180–1.Google Scholar

Barinagarrementería, F. and Cantú, C. 1998. Frequency of cerebral arteritis in subarachnoid cysticercosis. An angiographic study. Stroke, 29, 123–5.Google Scholar

Barinagarrementeria, F. and Del Brutto, O. H. 1988a. Neurocysticercosis and pure motor hemiparesis. Stroke, 19, 1156–8.Google Scholar

Barinagarrementeria, F. and Del Brutto, O. H. 1988b. Ataxic hemiparesis from parenchymal brain cysticercosis. J Neurol, 235, 325.Google Scholar

Barinagarrementeria, F. and Del Brutto, O. H. 1989. Lacunar syndrome due to neurocysticercosis. Arch Neurol, 46, 415–7.Google Scholar

Barinagarrementeria, F., Del Brutto, O. H., and Otero, E. 1988. Ataxic hemiparesis from cysticercosis. Arch Neurol, 45, 246.Google Scholar

Bouldin, A., and Pinter, J. D. 2006. Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone. J Child Neurol, 21, 1064–7.Google Scholar

Cantú, C. and Barinagarrementería, F. 1996. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol, 53, 233–9.Google Scholar

Cantú, C., Villarreal, J., Soto, J. L., and Barinagarrementeria, F. 1998. Cerebral cysticercotic arteritis: Detection and follow-up by transcranial Doppler. Cerebrovasc Dis, 8, 2–7.Google Scholar

Cardenas, G., Guevara-Silva, E., Fleury, A., Sciutto, E., and Soto-Hernandez, J. L. 2012. Subarachnoid hemorrhage in neurocysticercosis. A direct or serendipitous association? Neurologist, 18, 324–38.Google Scholar

Catapano, M. S. and Marx, J. A. 1986. Central nervous system cysticercosis simulating an acute cerebellar hemorrhage. Ann Emerg Med, 15, 847–9.Google Scholar

Del Brutto, O. H. 1992. Cysticercosis and cerebrovascular disease: A review. J Neurol Neurosurg Psychiatry, 55, 252–4.Google Scholar

Del Brutto, O. H. 1997a. Albendazole therapy for subarachnoid cysticerci: Clinical and neuroimaging analysis of 17 patients. J Neurol Neurosurg Psychiatry, 62, 659–61.Google Scholar

Del Brutto, O. H. 1997b. Clues to prevent cerebrovascular hazards of cysticidal drug therapy. Stroke, 28, 1088.Google Scholar

Del Brutto, O. H. 2005. Neurocysticercosis. Semin Neurol, 25, 243–51.Google Scholar

Del Brutto, O. H. 2012. Neurocysticercosis among international travelers to disease-endemic areas. J Travel Med, 19, 112–7Google Scholar

Del Brutto, O. H., Lama, J., for the Atahualpa Project Investigators. 2013. The importance of neurocysticercosis in stroke in rural areas of a developing Latin American country. Am J Trop Med Hyg, 89, 374–5.Google Scholar

Del Brutto, O. H., Sotelo, J., Aguirre, R., Diaz-Calderon, E., and Alarcón, T. A. 1992. Albendazole therapy for giant subarachnoid cysticerci. Arch Neurol, 49, 535–8.Google Scholar

Del Brutto, O. H. and Garcia, H. H. 2014. Cysticercosis of the human nervous system. Heildelberg: Springer-Verlag.Google Scholar

Dolpogol, V. B. and Neustaedter, M. 1935. Meningo-encephalitis caused by Cysticercus cellulosae. Arch Neurol Psychiatry, 33, 132–47.Google Scholar

Eboli, P., Drazin, D., Bannykh, S. I., and Schievink, W. 2012. Surgical management and role of medical therapy in unruptured aneurysmal neurocysticercosis. A case report and review of the literature. Neuroradiol J, 25, 337–41.Google Scholar

Escobar, A. and Weidenheim, K. M. 2002. The pathology of neurocysticercosis. In Taenia Solium Cysticercosis. From Basic to Clinical Science, eds. Singh, G., and Prabhakar, S.. Oxford: CAB International, pp. 289–305.Google Scholar

García, H. H., Nash, T. E., and Del Brutto, O. H. 2014. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol, 13, 1202–15.Google Scholar

García, H. H., Evans, C. A. W., Nash, T. E., et al. 2002. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev, 15, 747–56.Google Scholar

Gauthier, N., Sangla, S., Stroh-Marcy, A., and Payen, L. 1995. Neurocysticercose révélée par un accident vasculaire cérébral. J Radiol, 76, 119–23.Google Scholar

Guevara-Dondé, J. E., Gadea-Nieto, M. S., and Gómez-Llata, A. S. 1987. Cisticerco recubriendo un aneurisma de la arteria basilar. Arch Inst Nac Neurol Neurocir Mex, 2, 41–2.Google Scholar

Henneberg, R. 1912. Die tierischen parasiten des zentralnervensystems. I. Des Cysticercus cellulosae. In Handbuch der Neurologie, Vol III, Spezielle Neurologie II, ed. Lewandowsky, M.. Berlin: Verlag von Julius Springer, pp. 642–83.Google Scholar

Huang, P. P., Choudhri, H. F., Jallo, G., and Miller, D. C. 2000. Inflammatory aneurysm and neurocysticercosis: Further evidence for a causal relationship? Case report. Neurosurgery, 47, 466–7.Google Scholar

Jha, S. and Kumar, V. 2000. Neurocysticercosis presenting as stroke. Neurol India, 48, 391–4.Google Scholar

Kim, I. Y., Kim, T. S., Lee, J. H., et al. 2005. Inflammatory aneurysm due to neurocysticercosis. J Clin Neurosci, 12, 585–8.Google Scholar

Kohli, A., Gupta, R., and Kishore, J. 1997. Anterior cerebral artery infarction in neurocysticercosis: Evaluation by MR angiography and in vivo proton MR spectroscopy. Pediatr Neurosurg, 26, 93–6.Google Scholar

Lee, S. I. and Chang, G. Y. 1998. Recurrent brainstem transient ischemic attacks due to neurocysticercosis: A treatable cause. Eur Neurol, 40, 174–5.Google Scholar

Levy, A. S., Lillehei, K. O., Rubinstein, D., and Stears, J. C. 1995. Subarachnoid neurocysticercosis with occlusion of the major intracranial arteries: Case report. Neurosurgery, 36, 183–8.Google Scholar

McCormick, G. F., Giannotta, S., Zee, C. S., and Fisher, M. 1983. Carotid occlusion in cysticercosis. Neurology, 33, 1078–80.Google Scholar

Moniz, E., Loff, R., and Pacheco, L. 1932. Sur le diagnostic de la cysticercose cérébrale. L’Encephale, 27, 42–53.Google Scholar

Marquez, J. M. and Arauz, A. 2012. Cerebrovascular complications of neurocysticercosis. Neurologist 18, 17–22.CrossRef Google Scholar PubMed

Monteiro, L., Almeida-Pinto, J., Leite, I., Xavier, J., and Correia, M. 1994. Cerebral cysticercus arteritis: Five angiographic cases. Cerebrovasc Dis, 4, 125–33.Google Scholar

Murrell, K. D. 2005. WHO/FAO/OIE Guidelines for the Surveillance, Prevention and Control of Taeniosis/Cysticercosis. Paris: Office International des Epizooties.Google Scholar

Pittella, J. E. H. 1997. Neurocysticercosis. Brain Pathol, 7, 681–93.Google Scholar

Rocha, M. S. G., Brucki, S. M. D., Ferraz, A. C., and Piccolo, A. C. 2001. Doença cerebrovascular e neurocisticercose. Arq Neuropsiquiatr, 59, 778–83.Google Scholar

Rodriguez-Carbajal, J., Del Brutto, O. H., Penagos, P., Huebe, J., and Escobar, A. 1989. Occlusion of the middle cerebral artery due to cysticercotic angiitis. Stroke, 20, 1095–9.Google Scholar

Soto-Hernández, J. L., Gomez-Llata, S. A., Rojas-Echeverri, L. A., et al. 1996. Subarachnoid hemorrhage secondary to a ruptured inflammatory aneurysm. A possible complication of neurocysticercosis: Case report. Neurosurgery, 38, 197–9.Google Scholar

Tellez-Zenteno, J. F., Negrete-Pulido, O. R., Cantú, C., et al. 2003. Hemorrhagic stroke associated to neurocysticercosis. Neurología, 18, 272–5.Google Scholar

terPenning, B., Litchman, C. D., and Heier, L. 1992. Bilateral middle cerebral artery occlusions in neurocysticercosis. Stroke, 23, 280–3.Google Scholar

Trelles, J. O. and Ravens, R. 1953. Estudios sobre neurocisticercosis. II. Lesiones vasculares, meníngeas, ependimarias y neuró glicas. Revista de Neuro-Psiquiatría, 16, 241–70.Google Scholar

Viola, G. M., White, C. Jr., and Serpa, J. A. 2012. Hemorrhagic cerebrovascular events of neurocysticercosis: A case report and review of the literature. Am J Trop Med Hyg, 84, 402–5.Google Scholar

Wallin, M. T. and Kurtzke, J. F. 2004. Neurocysticercosis in the United States. Review of an important emerging infection. Neurology, 63, 1559–64.Google Scholar

Woo, E., Yu, Y. L., and Huang, C. Y. 1988. Cerebral infarct precipitated by praziquantel in neurocysticercosis: A cautionary note. Trop Geogr Neurol, 40, 143–6.Google Scholar

Wraige, E., Graham, J., Robb, S. A., and Jan, W. 2003. Neurocysticercosis masquerading as a cerebral infarct. J Child Neurol, 18, 298–300.Google Scholar

References

Antonara, S., Ristow, L., and Coburn, J. (2011). Adhesion mechanisms of Borrelia burgdorferi. Adv Exp Med Biol 715: 35–49.Google Scholar

Back, T., Grunig, S., Winter, Y., et al. (2013). Neuroborreliosis-associated cerebral vasculitis: Long-term outcome and health-related quality of life. J Neurol 260: 1569–75.Google Scholar

Banerjee, A., Kim, B. J., Carmona, E. M., et al. (2011). Bacterial Pili exploit integrin machinery to promote immune activation and efficient blood-brain barrier penetration. Nat Commun 2: 462.Google Scholar

Berglund, J., Eitrem, R., Ornstein, K., et al. (1995). An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 333: 1319–27.Google Scholar

Bodilsen, J., Dalager-Pedersen, M., Schonheyder, H. C., and Nielsen, H. (2014). Stroke in community-acquired bacterial meningitis: A Danish population-based study. Int J Infect Dis 20: 18–22.Google Scholar

Brogan, G. X., Homan, C. S., and Viccellio, P. (1990). The enlarging clinical spectrum of Lyme disease: Lyme cerebral vasculitis, a new disease entity. Ann Emerg Med 19: 572–6.Google Scholar

Brouqui, P., Bacellar, F., Baranton, G., et al. (2004). Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect 10: 1108–32.Google Scholar

CDC ( (2015a). Pneumococcal disease. Retrieved October 25, 2015 from http://www.cdc.gov/pneumococcal/clinicians/clinical-features.html.Google Scholar

CDC (2015b). Meningococcal Disease: Technical & Clinical Information. Retrieved October 25, 2015, 2015, from http://www.cdc.gov/meningococcal/clinical-info.html.Google Scholar

CDC (2015c). Group B strep (GBS). Retrieved October 25, 2015 from http://www.cdc.gov/groupbstrep/clinicians/clinical-overview.html.Google Scholar

CDC (2015d). Listeria (Listeriosis). Retrieved October 25, 2015, from http://www.cdc.gov/listeria/statistics.html.Google Scholar

Chehrenama, M., Zagardo, M., and Koski, C. (1997). Subarachnoid hemorrhage in a patient with Lyme disease. Neurology 48: 520–3.Google Scholar

Cheshier, R., Tu, E., Glaser, C., et al. (2003). Outbreaks of aseptic meningitis associated with echoviruses 9 and 30 and preliminary surveillance reports on enterovirus activity – United States, 2003. MMWR 52: 761–4.Google Scholar

Corral, I., Quereda, C., Guerrero, A., Escudero, R., and Marti-Belda, P. (1997). Neurological manifestations in patients with sera positive for Borrelia burgdorferi. Neurologia 12: 2–8.Google Scholar

Cox, M. G., Wolfs, T. F., Lo, T. H., Kappelle, L. J., and Braun, K. P. (2005). Neuroborreliosis causing focal cerebral arteriopathy in a child. Neuropediatrics 36: 104–7.Google Scholar

Deloizy, M., Devos, P., Stekelorom, T., Testard, D., and Belhadia, A. (2000). Left sided sudden hemiparesis linked to a central form of Lyme disease. Rev Neurol (Paris) 156: 1154–6.Google Scholar

Halperin, J. J. (2003). Lyme disease and the peripheral nervous system. Muscle & Nerve 28: 133–43.Google Scholar

Halperin, J., Logigian, E., Finkel, M., and Pearl, R. (1996). Practice parameter for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology 46: 619–27.Google Scholar

Hammers-Berggren, S., Grondahl, A., Karlsson, M., et al. (1993). Screening for neuroborreliosis in patients with stroke. Stroke 24: 1393–6.Google Scholar

Hanny, P. E. and Hauselmann, H. J. (1987). Die Lyme-Krankheit aus der Sicht des Neurologen. Schwiez med Wsch 117: 901–15.Google Scholar

Heinrich, A., Khaw, A. V., Ahrens, N., Kirsch, M., and Dressel, A. (2003). Cerebral vasculitis as the only manifestation of Borrelia burgdorferi infection in a 17-year-old patient with basal ganglia infarction. Eur Neurol 50: 109–12.Google Scholar

Henriksen, T. B. (1997). Lyme neuro-borreliosis in a 66-year old women. Differential diagnosis of cerebral metastases and cerebral infarction. Ugeskr Laeger 159: 3175–7.Google Scholar

Jacobi, C., Schwark, C., Kress, B., et al. (2006). Subarachnoid hemorrhage due to Borrelia burgdorferi-associated vasculitis. Eur J Neurol 13: 536.Google Scholar

Kastenbauer, S. and Pfister, H. W. (2003). Pneumococcal meningitis in adults: Spectrum of complications and prognostic factors in a series of 87 cases. Brain 126: 1015–25.Google Scholar

Keil, R., Baron, R., Kaiser, R., and Deuschl, G. (1997). Vasculitis course of neuroborreliosis with thalamic infarct. Nervenarzt 68: 339–41.Google Scholar

Klein, M., Koedel, U., Pfefferkorn, T., et al. (2011). Arterial cerebrovascular complications in 94 adults with acute bacterial meningitis. Crit Care 15: R281.Google Scholar

Klingebiel, R., Benndorf, G., Schmitt, M., von Moers, A., and Lehmann, R. (2002). Large cerebral vessel occlusive disease in Lyme neuroborreliosis. Neuropediatrics 33: 37–40.Google Scholar

Koedel, U., Scheld, W. M., and Pfister, H. W. (2002). Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2: 721–36.Google Scholar

Kohler, J., Kern, U., Kasper, J., Rhese-Kupper, B., and Thoden, U. (1988). Chronic central nervous system involvement in Lyme borreliosis. Neurology 38: 863–7.Google Scholar

Kurian, M., Pereira, V. M., Vargas, M. I., and Fluss, J. (2015). Stroke-like phenomena revealing multifocal cerebral vasculitis in pediatric Lyme neuroborreliosis. J Child Neurol 30: 1226–9.Google Scholar

Laroche, C., Lienhardt, A., and Boulesteix, J. (1999). Ischemic stroke caused by neuroborreliosis. Arch Pediatr 6: 1302–5.Google Scholar

Lebas, A., Toulgoat, F., Saliou, G., Husson, B., and Tardieu, M. (2012). Stroke due to Lyme neuroborreliosis: Changes in vessel wall contrast enhancement. J Neuroimaging 22: 210–12.Google Scholar

Li, S., Vytopil, M., Hreib, K., and Craven, D. E. (2015). Lyme disease presenting as multiple ischaemic strokes. Pract Neurol 15: 284–8.Google Scholar

May, E. F. and Jabbari, B. (1990). Stroke in neuroborreliosis. Stroke 21: 1232–5.Google Scholar

Midgard, R. and Hofstad, H. (1987). Unusual manifestations of nervous system Borrelia burgdorferi infection. Arch Neurol 44: 781–3.Google Scholar

Mygland, A., Ljostad, U., Fingerle, V., et al. (2010). EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17: 8–16, e11–14.Google Scholar

Nagel, M. A. and Gilden, D. (2015). The relationship between herpes zoster and stroke. Curr Neurol Neurosci Rep 15: 16.Google Scholar

Oksi, J., Kalimo, H., Marttila, R. J., et al. (1996). Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 119: 2143–54.Google Scholar

Oksi, J., Kalimo, H., Marttila, R. J., et al. (1998). Intracranial aneurysms in three patients with disseminated Lyme borreliosis: Cause or chance association? J Neurol Neurosurg Psychiatry 64: 636–42.Google Scholar

Olarte, L., Barson, W. J., Barson, R. M., et al. (2015). Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children. Clin Infect Dis 61: 767–75.Google Scholar

Olsson, J. E. and Zbornikova, V. (1990). Neuroborreliosis simulating a progressive stroke. Acta Neurol Scand 81: 471–4.Google Scholar

Orihuela, C. J., Mahdavi, J., Thornton, J., et al. (2009). Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J Clin Invest 119: 1638–46.Google Scholar

Reik, L. Jr. (1993). Stroke due to Lyme disease. Neurology 43: 2705–7.Google Scholar

Renard, C., Marignier, S., Gillet, Y., et al. (2008). Acute hemiparesis revealing a neuroborreliosis in a child. Arch Pediatr 15: 41–4.Google Scholar

Rey, V., Du Pasquier, R., Muehl, A., Peter, O., and Michel, P. (2010). Multiple ischemic strokes due to Borrelia garinii meningovasculitis. Rev Neurol (Paris) 166: 931–4.Google Scholar

Roberts, E. D., Bohm, R. P. Jr., Lowrie, R. C. Jr., et al. (1998). Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: The early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 178: 722–32.Google Scholar

Romi, F., Krakenes, J., Aarli, J. A., and Tysnes, O. B. (2004). Neuroborreliosis with vasculitis causing stroke-like manifestations. Eur Neurol 51: 49–50.Google Scholar

Roos, K. J., Tunkel, A. R., van de Beek, D., and Scheld, M. (2014). Acute bacterial meningitis. In Infections of the Central Nervous Systtem, eds. Scheld, M., Whitley, J. W. and Marra, C. M.. Philadelphia: Wolters Kluwer Health.Google Scholar

Scheid, R., Hund-Georgiadis, M., and von Cramon, D. Y. (2003). Intracerebral haemorrhage as a manifestation of Lyme neuroborreliosis? Eur J Neurol 10: 99–101.Google Scholar

Schmiedel, J., Gahn, G., von Kummer, R., and Reichmann, H. (2004). Cerebral vasculitis with multiple infarcts caused by Lyme disease. Cerebrovasc Dis 17: 79–81.Google Scholar

Schmitt, A. B., Kuker, W., and Nacimiento, W. (1999). Neuroborreliosis with extensive cerebral vasculitis and multiple cerebral infarcts. Nervenarzt 70: 167–71.Google Scholar

Schoen, F. J. (2005). Blood vessels. In Robbins & Cotran, Pathologic Basis of Disease, eds. Kumar, V., Abbas, A. K. and Fausto, N.. Elsevier Saunders: pp. 511–537.Google Scholar

Schuchat, A. (1998). Epidemiology of group B streptococcal disease in the United States: Shifting paradigms. Clin Microbiol Rev 11: 497–513.Google Scholar

Schut, E. S., Brouwer, M. C., de Gans, J., et al. (2009). Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology 73: 1988–95.Google Scholar

Seijo Martinez, M., Grandes Ibanez, J., Sanchez Herrero, J., and Garcia-Monco, J. C. (2001). Spontaneous brain hemorrhage associated with Lyme neuroborreliosis. Neurologia 16: 43–5.Google Scholar

Smeeth, L., Thomas, S. L., Hall, A. J., et al. (2004). Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351: 2611–18.Google Scholar

Sparsa, L., Blanc, F., Lauer, V., et al. (2009). Recurrent ischemic strokes revealing Lyme meningovascularitis. Rev Neurol (Paris) 165: 273–7.Google Scholar

Thigpen, M. C., Whitney, C. G., Messonnier, N. E., et al. (2011). Bacterial meningitis in the United States, 1998–2007. N Engl J Med 364: 2016–25.Google Scholar

Topakian, R., Stieglbauer, K., Nussbaumer, K., and Aichner, F. T. (2008). Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two case reports and review of current knowledge. Cerebrovasc Dis 26: 455–61.Google Scholar

Uldry, P. A., Regli, F., and Bogousslavsky, J. (1987). Cerebral angiopathy and recurrent strokes following Borrelia burgdorferi infection. J Neurol Nsurg & Psych 50: 1703–4.Google Scholar

Van Snick, S., Duprez, T. P., Kabamba, B., Van De Wyngaert, F. A., and Sindic, C. J. (2008). Acute ischaemic pontine stroke revealing lyme neuroborreliosis in a young adult. Acta Neurol Belg 108: 103–6.Google Scholar

Veenendaal-Hilbers, J. A., Perquin, W. V., Hoogland, P. H. and Doornbos, L. (1988). Basal meningovasculitis and occlusion of the basilar artery in two cases of Borrelia burgdorferi infection. Neurology 38: 1317–19.Google Scholar

Walsh, J. G., Muruve, D. A., and Power, C. (2014). Inflammasomes in the CNS. Nat Rev Neurosci 15: 84–97.Google Scholar

Wilke, M., Eiffert, H., Christen, H. J., and Hanefeld, F. (2000). Primarily chronic and cerebrovascular course of Lyme neuroborreliosis: Case reports and literature review. Arch Dis Child 83: 67–71.Google Scholar

Wittwer, B., Pelletier, S., Ducrocq, X., et al. (2015). Cerebrovascular events in Lyme neuroborreliosis. J Stroke Cerebrovasc Dis 24: 1671–8.Google Scholar

Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., et al. (2006). The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43: 1089–134.Google Scholar

Zhang, Y., Lafontant, G., and Bonner, F. J. Jr. (2000). Lyme neuroborreliosis mimics stroke: A case report. Arch Phys Med Rehabil 81: 519–21.Google Scholar

References

Kawasaki, T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16, 178–222 (1967).Google Scholar

Bell, D. M., Morens, D. M., Holman, R. C., Hurwitz, E. S., & Hunter, M. K. Kawasaki syndrome in the United States 1976 to 1980. Am J Dis Child 137, 211–14 (1983).Google Scholar

Ferro, J. M. Vasculitis of the central nervous system. J Neurol 245, 766–76 (1998).Google Scholar

Morens, D. M. & O’Brien, R. J. Kawasaki disease in the United States. J Infect Dis 137, 91–93 (1978).Google Scholar

Amano, S. & Hazama, F. Neural involvement in Kawasaki disease. Acta Pathol Jpn 30, 365–73 (1980).Google Scholar

Amano, S., Hazama, F., & Hamashima, Y. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn Circ J 43, 741–8 (1979).Google Scholar

Tanaka, S., Sagiuchi, T., & Kobayashi, I. Ruptured pediatric posterior cerebral artery aneurysm 9 years after the onset of Kawasaki disease: A case report. Childs Nerv Syst 23, 701–6 (2007).Google Scholar

Shulman, S. T. & Rowley, A. H. Etiology and pathogenesis of Kawasaki disease. Progress in Pediatric Cardiology 6, 187–92 (1997).Google Scholar

Yanagawa, H., et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 107, E33 (2001).Google Scholar

Yanagawa, H., et al. Incidence of Kawasaki disease in Japan: The nationwide surveys of 1999–2002. Pediatr Int 48, 356–61 (2006).Google Scholar

Burns, J. C., et al. Kawasaki disease: A brief history. Pediatrics 106, E27 (2000).Google Scholar

Kawasaki, T., Kosaki, F., Okawa, S., Shigematsu, I., & Yanagawa, H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54, 271–6 (1974).Google Scholar

Newburger, J. W., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114, 1708–33 (2004).Google Scholar

Cheung, Y. F., et al. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 122, e608–14 (2008).Google Scholar

Jackson, J. L., Kunkel, M. R., Libow, L., & Gates, R. H. Adult Kawasaki disease. Report of two cases treated with intravenous gamma globulin. Arch Intern Med 154, 1398–405 (1994).Google Scholar

Rauch, A. M. Kawasaki syndrome: Issues in etiology and treatment. Adv Pediatr Infect Dis 4, 163–82 (1989).Google Scholar

Chang, R. K. Hospitalizations for Kawasaki disease among children in the United States, 1988–1997. Pediatrics 109, e87 (2002).Google Scholar

Dillon, M. J. & Ozen, S. A new international classification of childhood vasculitis. Pediatr Nephrol 21, 1219–22 (2006).Google Scholar

Ozen, S., et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65, 936–41 (2006).Google Scholar

Amano, S., Hazama, F., & Hamashima, Y. Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jpn Circ J 43, 633–43 (1979).Google Scholar

Amano, S., et al. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 30, 681–94 (1980).Google Scholar

Mason, W. H., Burns, J. C. Clinical presentation of Kawasaki disease. Progress in Pediatric Cardiology 6, 193–201 (1997).Google Scholar

Dajani, A. S., et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 87, 1776–80 (1993).Google Scholar

Newburger, J. W., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110, 2747–71 (2004).Google Scholar

Newburger, J. W., Burns, J. C., Beiser, A. S., & Loscalzo, J. Altered lipid profile after Kawasaki syndrome. Circulation 84, 625–31 (1991).Google Scholar

Dengler, L. D., et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J 17, 478–81 (1998).Google Scholar

Tabarki, B., Mahdhaoui, A., Selmi, H., Yacoub, M., & Essoussi, A. S. Kawasaki disease with predominant central nervous system involvement. Pediatr Neurol 25, 239–41 (2001).Google Scholar

Terasawa, K., Ichinose, E., Matsuishi, T., & Kato, H. Neurological complications in Kawasaki disease. Brain Dev 5, 371–4 (1983).Google Scholar

Bailie, N. M., Hensey, O. J., Ryan, S., Allcut, D., & King, M.D. Bilateral subdural collections–an unusual feature of possible Kawasaki disease. Eur J Paediatr Neurol 5, 79–81 (2001).Google Scholar

Fujiwara, S., Yamano, T., Hattori, M., Fujiseki, Y., & Shimada, M. Asymptomatic cerebral infarction in Kawasaki disease. Pediatr Neurol 8, 235–6 (1992).Google Scholar

Knott, P. D., Orloff, L. A., Harris, J. P., Novak, R. E., & Burns, J.C. Sensorineural hearing loss and Kawasaki disease: A prospective study. Am J Otolaryngol 22, 343–8 (2001).Google Scholar

Koutras, A. Myositis with Kawasaki’s disease. Am J Dis Child 136, 78–9 (1982).Google Scholar

Lapointe, J. S., Nugent, R. A., Graeb, D. A., & Robertson, W. D. Cerebral infarction and regression of widespread aneurysms in Kawasaki’s disease: Case report. Pediatr Radiol 14, 1–5 (1984).Google Scholar

Laxer, R. M., Dunn, H. G., & Flodmark, O. Acute hemiplegia in Kawasaki disease and infantile polyarteritis nodosa. Dev Med Child Neurol 26, 814–18 (1984).Google Scholar

Suda, K., Matsumura, M., & Ohta, S. Kawasaki disease complicated by cerebral infarction. Cardiol Young 13, 103–5 (2003).Google Scholar

Templeton, P. A. & Dunne, M. G. Kawasaki syndrome: Cerebral and cardiovascular complications. J Clin Ultrasound 15, 483–5 (1987).Google Scholar

Wada, Y., Kamei, A., Fujii, Y., Ishikawa, K., & Chida, S. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease. J Pediatr 148, 399–400 (2006).Google Scholar

Sabatier, I., et al. Stroke by carotid artery complete occlusion in Kawasaki disease: Case report and review of literature. Pediatr Neurol 49, 469–73 (2013).Google Scholar

Boespflug, O., Tardieu, M., Losay, J., & Leroy, D. Acute hemiplegia complicating Kawasaki disease. Rev Neurol (Paris) 140, 507–9 (1984).Google Scholar

Hosaki, J., Abe, S., Shoback, B. R., Yoshimatu, A., & Migita, T. Mucocutaneous lymph node syndrome with various arterial lesions. Helv Paediatr Acta 33, 127–33 (1978).Google Scholar

Lauret, P., Lecointre, C., & Billard, J. L. Kawasaki disease complicated by thrombosis of the internal carotid artery. Ann Dermatol Venereol 106, 901–5 (1979).Google Scholar

Beiser, A. S., Takahashi, M., Baker, A. L., Sundel, R. P., & Newburger, J. W. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 81, 1116–20 (1998).Google Scholar

Muneuchi, J., et al. Magnetic resonance studies of brain lesions in patients with Kawasaki disease. Brain Dev 28, 30–3 (2006).Google Scholar

Ahn, J. H., Phi, J. H., Kang, H. S. et al., J Neurosurg Pediatric 6, 150–153 (2010).Google Scholar

Ichiyama, T., et al. Cerebral hypoperfusion during acute Kawasaki disease. Stroke 29, 1320–1 (1998).Google Scholar

Sato, T., et al. Kawasaki disease-associated MERS: Pathological insights from SPECT findings. Brain Dev 34, 605–8 (2012).Google Scholar

Takanashi, J., et al. Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci 315, 167–9 (2012).Google Scholar

Benseler, S. M., et al. Primary central nervous system vasculitis in children. Arthritis Rheum 54, 1291–7 (2006).Google Scholar

Kato, H., Koike, S., & Yokoyama, T. Kawasaki disease: Effect of treatment on coronary artery involvement. Pediatrics 63, 175–9 (1979).Google Scholar

Newburger, J. W., et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 356, 663–75 (2007).Google Scholar

Newburger, J. W., et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315, 341–7 (1986).Google Scholar

Newburger, J. W., et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324, 1633–9 (1991).Google Scholar

Furusho, K., et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2, 1055–8 (1984).Google Scholar

Sundel, R. & Newburger, J. W. Management of acute Kawasaki disease. Progress in Pediatric Cardiology 6, 203–9 (1997).Google Scholar

Alehan, F. K., Boyvat, F., Baskin, E., Derbent, M., & Ozbek, N. Focal cerebral vasculitis and stroke after chickenpox. Eur J Paediatr Neurol 6, 331–3 (2002).Google Scholar

deVeber, G., Roach, E. S., Riela, A. R., & Wiznitzer, M. Stroke in children: Recognition, treatment, and future directions. Semin Pediatr Neurol 7, 309–17 (2000).Google Scholar

Takeoka, M. & Takahashi, T. Infectious and inflammatory disorders of the circulatory system and stroke in childhood. Curr Opin Neurol 15, 159–64 (2002).Google Scholar

Israels, S. J. & Michelson, A. D. Antiplatelet therapy in children. Thromb Res 118, 75–83 (2006).Google Scholar

Bayers, S., Shulman, S. T., & Paller, A. S. Kawasaki disease: Part II. Complications and treatment. J Am Acad Dermatol 69, 513 e511–518 (2013).Google Scholar

References

Antunes, AF, Maduro, SG, Pereira, BV, et al. Chronic heart disease after treatment of oral acute Chagas disease. Arq Bras Cardiol 2016;107:184–6.Google Scholar

Aras, R, da Matta, JA, Mota, G, et al. Cerebral infarction in autopsies of chagasic patients with heart failure. Arq Bras Cardiol 2003;81:414–16.Google Scholar

Aufderheide, AC, Salo, W, Madden, M, et al. A 9,000 year record of Chagas’ disease. Proc Natl Acad Sci USA 2004;101:2034–9.Google Scholar

Basquiera, AL, Sembaj, A, Aguerri, AM, et al. Risk progression to chronic Chagas cardiomyopathy: Influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 2003;89:1186–90.Google Scholar

Belisario Falchetto, E, Costa, SC, Rochitte, CE. Diagnostic challenges of Chagas cardiomyopathy and CMR imaging. Glob Heart 2015;10:181–7.Google Scholar

Benaim, G, Paniz Mondolfi, AE. The emerging role of amiodarone and dronedarone in Chagas disease. Nat Rev Cardiol 2012;9:605–9.Google Scholar

Benedictus, MR, Leeuwis, AE, Binnewijzend, MA, et al. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease. Eur Radiol 2016; in press.Google Scholar

Benvenuti, LA, Roggério, A, Freitas, HF, et al. Chronic American trypanosomiasis: Parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann Trop Med Parasitol 2008;102:481–7.Google Scholar

Bern, C. Chagas disease in the immunosuppressed host. Cur Opin Infect Dis 2012;25:450–7.Google Scholar

Bern, C. Chagas’ disease. N Engl J Med 2015;373:456–66.Google Scholar

Bern, C, Montgomery, SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009;49:e52–4.Google Scholar

Bern, C, Martin, DL, Gilman, RH. Acute and congenital Chagas disease. Adv Parasitol 2011;75:19–47.Google Scholar

Bestetti, RB, Freitas, OC, Muccillo, G, et al. Clinical and morphological characteristics associated with sudden cardiac death in patients with Chagas’ disease. Eur Heart J 1993;14:1610–14.Google Scholar

Bestetti, RB, Restini, CB, Couto, LB. Carlos Chagas discoveries as a drop back to scientific construction of chronic Chagas heart disease. Arq Bras Cardiol 2016;107:63–70.Google Scholar

Braga, J, Labrunie, A, Villaça, F, et al. Thromboembolism in chronic Chagas’ heart disease. São Paulo Med J 1995;113:862–6.Google Scholar

Braga, JC, Reis, F, Aras, R, et al. Clinical and therapeutics aspects of heart failure due to Chagas disease. Arq Bras Cardiol 2006;86:297–302.Google Scholar

Braggion-Santos, MF, Volpe, GJ, Pazin-Filho, A, et al. Sudden cardiac death in Brazil: A community-based autopsy series (2006–2010). Arq Bras Cardiol 2015;104:120–7.Google Scholar

Cardoso, AV, Lescano, SA, Amato Neto, V, et al. Survival of Trypanosoma cruzi in sugar cane used to prepare juice. Rev Inst Med Trop Sao Paulo 2006;48:287–9.Google Scholar

Carod-Artal, FJ. Stroke: A neglected complication of American trypanosomiasis (Chagas’ disease). Trans R Soc Trop Med Hyg 2007;1–1:1075–80.Google Scholar

Carod-Artal, FJ. Policy implications of the changing epidemiology of Chagas disease and stroke. Stroke 2013;44:2356–60.Google Scholar

Carod-Artal, FJ, Vargas, AP, Melo, M, et al. American trypanosomiasis (Chagas’ disease): An unrecognized cause of stroke. J Neurol Neurosurg Psychiatry 2003;74:516–18.Google Scholar

Carod-Artal, FJ, Vargas, AP, Horan, TA, et al. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 2005;36:965–70.Google Scholar

Chagas, C. Nova tripanozomiaze humana. Estudo sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n.gen. n.sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1909; 1:159–218.Google Scholar

Cougo-Pinto, PT, dos Santos, BL, Dias, FA, et al. Safety of IV thrombolysis in acute ischemic stroke related to Chagas disease. Neurology 2013;81:1773–5.Google Scholar

Corral, RS, Guerrero, NA, Cuervo, H, et al. Trypanosoma cruzi infection and endothelin-1 cooperatively activate pathogenic inflammatory pathways in cardiomyocytes. PLoS Negl Trop Dis 2013;7:e2034.Google Scholar

da Matta, JA, Aras, R Jr, de Macedo, CR, et al. Stroke correlates in chagasic and non-chagasic cardiomyopathies. PLoS One 2012;7:e35116.Google Scholar

de Andrade, AL de, Zicker, F, de Oliveira, RM, et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996;348:1407–13.Google Scholar

Dias, JC. The indeterminate form of human chronic Chagas’ disease. A clinical epidemiological review. Rev Soc Bras Med Trop 1989;22:147–56.Google Scholar

Dias, JC. Evolution of Chagas disease screening programs and control programs: Historical perspective. Glob Heart 2015;10:193–202.Google Scholar

Dias, JC, Silveira, AC, Schofield, CJ. The impact of Chagas disease control in Latin America: A review. Mem Inst Oswaldo Cruz 2002;97:603–12.Google Scholar

Dias, JO Jr, da Costa Rocha, MO, de Souza, AC, et al. Assessment of the source of ischemic cerebrovascular events in patients with Chagas disease. Int J Cardiol 2014;176:1352–4.Google Scholar

Forsyth, CJ, Hernandez, S, Olmedo, W et al. Safety profile of nifurtimox for treatment of Chagas disease in the United States. Clin Infect Dis 2016;63:1056–62.Google Scholar

Gurgel, CB, Ferreira, MC, Mendes, CR, et al. Apical lesions in Chagas’ heart disease patients: An autopsy study. Rev Soc Bras Med Trop 2010;43:709–12.Google Scholar

Jesus, PA, Neville, I, Cincura, C, et al. Stroke history and Chagas disease are independent predictors of silent cerebral microembolism in patients with congestive heart failure. Cerebrovasc Dis 2011;31:19–23.Google Scholar

Kalil Filho, R, de Albuquerque, CP. Magnetic resonance imaging in Chagas heart disease. São Paulo Med J 1995;113:880–3.Google Scholar

Kuehn, BM. Chagas heart disease an emerging concern in the United States. Circulation 2016;134:895–6.Google Scholar

Lee-Felker, SA, Thomas, M, Felker, ER, et al. Value of cardiac MRI for evaluation of chronic Chagas disease cardiomyopathy. Clin Radiol 2016;71:618.e1–7.Google Scholar

Lewis, MD, Kelly, JM. Putting infection dynamics at the heart of Chagas disease. Trends Parasitol 2016 epub ahead of print.Google Scholar

Lorga Filho, AM, Azmus, AD, Soeiro, AM, et al. Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology. Arq Bras Cardiol 2013;10 (Suppl 3): 1–95.Google Scholar

Mady, C, Cardoso, RHA, Barretto, AC et al. Survival and predictors of survival in patients with congestive heart failure due to Chagas’ cardiomyopathy. Circulation 1994;90:3098–102.Google Scholar

Marcolino, MS, Palhares, DM, Ferreira, LR, et al. Electrocardiogram and Chagas disease: A large population database of primary care patients. Glob Heart 2015;10:167–72.Google Scholar

Martí-Carvajal, AJ, Kwong, JS. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy. Cochrane Database Syst Rev 2016;7:CD009077Google Scholar

Massaro, AR, Dutra, AP, Almeida, DR, et al. Transcranial Doppler assessment of cerebral blood flow: Effect of cardiac transplantation. Neurology 2006;66:124–6.Google Scholar

Miles, MA, Feliciangeli, MD, de Arias, AR. American trypanosomiasis (Chagas’ disease) and the role of molecular epidemiology in guiding control strategies. BMJ 2003;326:1444–8.Google Scholar

Montanaro, VV, da Silva, CM, de Viana Santos, CV, et al. Ischemic stroke classification and risk of enosis in patients with Chagas disease. J Neurol 2016; 263:2411–15.Google Scholar

Morel, CM. Chagas disease, from discovery to control – and beyond: History, myths and lessons to take home. Mem Inst Oswaldo Cruz 1999;94 Suppl 1:3–16.Google Scholar

Morillo, CA, Marin-Neto, JA, Avezum, A, et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med 2015;373(14):1295–306.Google Scholar

Nunes, MC, Barbosa, MM, Ribeiro, AL, et al. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: A prospective follow-up study. J Neurol Sci 2009;278:96–101.Google Scholar

Nunes, MC, Dones, W, Morillo, CA, et al. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol 2013;62:767–76.Google Scholar

Nunes, MC, Kreuser, LJ, Ribeiro, AL, et al. Prevalence and risk factors of embolic cerebrovascular events associated with Chagas heart disease. Glob Heart 2015;10:151–7.Google Scholar

Oliveira-Filho, J, Viana, LC, Vieira de Melo, RM et al. Chagas disease is an independent risk factor for stroke: Baseline characteristics of Chagas disease cohort. Stroke 2005;36:2015–17.Google Scholar

Oliveira-Filho, J, Vieira-de-Melo, RM, Reis, PS, et al. Chagas disease is independently associated with brain atrophy. J Neurol 2009;256:1363–5.Google Scholar

Paixão, LC, Ribeiro, AL, Valacio, RA, et al. Chagas disease: Independent risk factor for stroke. Stroke 2009;40:3691–4.Google Scholar

Pazin-Filho, A, Romano, MM, Almeida-Filho, OC, et al. Minor segmental wall motion abnormalities detected in patients with Chagas’ disease have adverse prognostic implications. Braz J Med Biol Res 2006;39:483–7.Google Scholar

Peix, A, Garcia, R, Sánchez, J, et al. Myocardial perfusion imaging and cardiac involvement in the inderminate phase of Chagas disease. Arq Bras Cardiol 2013;100:114–17.Google Scholar

Pirard, M, Iihoshi, N, Boelaert, M, et al. The validity of serologic test for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005;45:554–61.Google Scholar

Pitella, JE. Ischemic cerebral changes in the chronic chagasic cardiopathy. Arq Neuropsiquiatr 1984;42:105–15.Google Scholar

Prata, A. Evolution of the clinical and epidemiological knowledge about Chagas disease 90 years after its discovery. Mem Inst Oswaldo Cruz 1999;94: Suppl 1:81–8.Google Scholar

Rassi, A Jr, Rassi, A, Little, WC, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med 2006;355:799–808.Google Scholar

Rassi, A Jr, Rassi, A, Marin-Neto, JA. Chagas disease. Lancet 2010;375:1388–402.Google Scholar

Rassi, DC, Vieira, ML, Arruda, AL, et al. Echocardiographic parameters and survival in Chagas heart disease with severe systolic dysfunction. Arq Bras Cardiol 2014;102:245–52.Google Scholar

Regueiro, A, García-Álvarez, A, Sitges, M, et al. Myocardial involvement in Chagas disease: Insights from cardiac magnetic resonance. Int J Cardiol 2013;165:107–12.Google Scholar

Requena-Méndez, A, Aldasoro, E, de Lazzari, E, et al. Prevalence of Chagas disease in Latin-American migrants living in Europe: A systematic review and meta-analysis. PLoS Negl Trop Dis 2015. February 13;9:e0003540Google Scholar

Requena-Méndez, A, Moore, DA, Subirà, C, et al. Addressing the neglect: Chagas disease in London, UK. Lancet Glob Health 2016;4:e231–3.Google Scholar

Ribeiro, AL, Rocha, MO. Indeterminate form of Chagas disease: Considerations about diagnosis and prognosis. Rev Soc Bras Med Trop 1998;31:301–14.Google Scholar

Rochitte, CE, Oliveira, PF, Andrade, JM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: A marker of disease severity. J Am Coll Cardiol 2005;46:1553–8.Google Scholar

Rothhammer, F, Allison, MJ, Núñez, L, et al. Chagas’ disease in pre-Columbian South America. Am J Phys Anthropol 1985;68:495–8.Google Scholar

Samuel, J, Oliveira, M, Correa de Araújo, RR, et al. Cardiac thrombosis and thromboembolism in chronic Chagas’ heart disease. Am J Cardiol 1983;52:147–51.Google Scholar

Schmunis, GA, Yadon, ZE. Chagas disease: A Latin American health problem becoming a world health problem. Acta Trop 2010;115:14–21.Google Scholar

Sousa, AS, Xavier, SS, de Freitas, FR, et al. Prevention strategies of cardioembolic ischemic stroke in Chagas disease. Arq Bras Cardiol 2008;91:280–4.Google Scholar

Trabuco, CC, Pereira de Jesus, PA, Bacellar, AS, et al. Successful thrombolysis in cardioembolic stroke from Chagas disease. Neurology 2005;64:170–1.Google Scholar

Torreão, JA, Ianni, BM, Mady, C, et al. Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2015;17:97.Google Scholar

Vilas Boas, LG, Bestetti, RB, Otaviano, AP, et al. Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy. Int J Cardiol 2013;167:486–90.Google Scholar

Viotti, RJ, Vigliano, C, Laucella, S, et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart 2004;90:655–60.Google Scholar

Walsh, JF, Molyneux, DH, Birley, MH. Deforestation: Effects on vector-borne disease. Parasitology 1993;106 (Suppl): S55–75.Google Scholar

World Health Organization (WHO). Chagas disease in Latin America: An epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 2015;90:33–43.Google Scholar

Yadon, ZE, Schmunis, GA. Congenital Chagas disease: Estimating the potential risk in the United States. Am J Trop Med Hyg 2009;81:927–33.Google Scholar

References

Abuaf, N., Laperche, S., Rajoely, B., et al. 1997. Auto antibodies to phospholipid and to the coagulation proteins in AIDS. Thromb Haemost, 77, 856–61.Google Scholar

Ake, J. A., Erikson, J. C., and Lowry, K. J. 2006. Cerebral aneurysmal arteriopathy associated with HIV infection in an adult. Clin Infect Dis, 43, e46–50.Google Scholar

Allie, S., Stanley, A., Bryer, A., Meiring, M., and Combrinck, M. I. 2015. High levels of von Willebrand factor and low levels of its cleaving protease, ADAMTS13, are associated with stroke in young HIV-infected patients. Int J Stroke, 10, 1294–6.Google Scholar

Anders, K. H., Guerra, W. F., Tomiyasu, U., Verity, M. A., and Vinters, H. V. 1986. The neuropathology of AIDS: UCLA experience and review. Am J Pathol, 124, 537–58.Google Scholar

Benjamin, L. A., Corbett, E. L., Connor, M.D., et al. 2016. HIV, antiretroviral treatment, hypertension and stroke in Malawian adults: A case-control study. Neurology, 86, 1–10.Google Scholar

Berger, J. R. 2004. AIDS and stroke risk. Lancet Neurol, 3, 206–7.Google Scholar

Berger, J. R., Harris, J. O., Gregarios, J., and Norenberg, M. 1990. Cerebrovascular disease in AIDS: A case control study. AIDS, 4, 239–44.Google Scholar

Bissuel, F., Berruyer, M., and Causse, X. 1992. Acquired protein S deficiency: Correlation with advanced disease in HIV-1 infected patients. J Acquir Immune Defic Syndr, 5, 484–9.Google Scholar

Budka, H. 1989. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: Pathology and implications for pathogenesis. Acta Neuropathol, 77, 225–36.Google Scholar

Budka, H., Costanzi, G., and Cristina, S. 1987. Brain pathology induced by infection with the human immunodeficiency virus (HIV): A histological, immunocytochemical and electron microscopical study of 100 autopsy cases. Acta Neuropathol (Berlin), 75, 185–98.Google Scholar

Burkholder, G. A., Tamhane, A. R., Salinas, J. L., et al. 2012. Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients. Clinical Infectious Diseases, 55, 11, 1550–7.Google Scholar

Calabrese, L. H. 1991. Vasculitis and infection with the human immunodeficiency virus. Rheum Dis Clin North Am, 17, 131–47.Google Scholar

Casado Naranjo, I., Toledo Santos, J. A., and Antolin Rodriguez, M. A. 1992. Ischemic stroke as the sole manifestation of human immunodeficiency virus infection. Stroke, 23, 117–8.Google Scholar

Chetty, R. 2005. Vasculitides associated with HIV infection. J Clin Pathol, 54, 275–8.Google Scholar

Chetty, R., Batitang, S., and Nair, R. 2000. Large artery vasculopathy in HIV positive patients. Another vasculitic enigma. Hum Pathol, 31, 374–9.Google Scholar

Choi, A. I., Vittinghoff, E., Deeks, S. G., et al. 2011. Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons. AIDS 25, 1289–98.Google Scholar

Chow, F. C., Regan, S., Feske, S., et al. 2012. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr, 60(4), 351–8.Google Scholar

Cole, J. W., Pinto, A. N., Hebel, J. R., et al. 2004. Acquired immunodeficiency syndrome and the risk of stroke. Stroke, 35, 51–6.Google Scholar

Cruciani, M., Zanichellib, V., Serpellonia, G., et al. 2011. Abacavir use and cardiovascular disease events: A meta-analysis of published and unpublished data. AIDS 25, 1993–2004.Google Scholar

Connor, M. D., Lammie, G. A., Bell, J. A., et al. 2000. Cerebral infarction in adult AIDS patients. Observations from the Edinburgh HIV autopsy cohort. Stroke, 31, 2117–26.Google Scholar

Dubrovsky, T., Curless, R., Scott, G., et al. 1998. Cerebral aneurysmal arteriopathy in childhood AIDS. Neurology, 51, 560–5.Google Scholar

Engstroom, J. W., Lowenstein, D. H., and Bredesen, D. E. 1989. Cerebral infarction and transient neurological deficits associated with acquired immune deficiency syndrome. AmJ Med, 86, 528–32.Google Scholar

Erbe, M., Rickerts, V., and Bauersachs, R. M. 2003. Acquired protein C and protein S deficiency in HIV infected patients. Clin Appl Thromb Haemost, 9, 325–31.Google Scholar

Evers, S., Nabavi, D., Ratiman, A., et al. 2003. Ischemic cerebrovascular events in HIV infection, a cohort study. Cerebrovasc Dis, 15, 199–205.Google Scholar

Freiberg, M. S., Chang, C. H., Kuller, L. H., and Skanderson, M. 2013. HIV Infection and the risk of acute myocardial infarction. JAMA Intern Med, 173, 614–22.Google Scholar

Friis-Møller, N., Thiébaut, R., Reiss, P., et al. for the DAD study group. 2010. Predicting the risk of cardiovascular disease in HIV-infected patients: The data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil, 17, 5, 491–501.Google Scholar

Gherardi, R., Belec, L., and Mhin, C. 1993. The spectrum of vasculitis in human immunodeficiency virus-infected patients. Arthritis Rheum, 36, 1164–74.Google Scholar

Gillams, A. R., Allen, E., Hrieb, K., et al. 1997. Cerebral infarction in patients with AIDS. AJNR Am J Neuroradiol, 18, 1581–5.Google Scholar

Gisselbrecht, M., Cohen, P., and Lortholary, D. 1998. Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases. Ann Med Interne (Paris), 149, 398–405.Google Scholar

Goeijenbier, M., van Wissen, M., van de Weg, C., et al. 2012. Viral infections and mechanisms of thrombosis and bleeding. J Med Virol 84, 1680–96.Google Scholar

Gutierrez, J. and Ortiz, G. 2011. HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: A case series. Clin Neuroradiol, 21, 145–51.Google Scholar

Hanna, D. B., Post, W. S., Deal, J. A., et al. 2015. HIV infection is associated with progression of subclinical carotid atherosclerosis. Clin Infect Dis 61, 640–50.Google Scholar

Hassell, K. L., Kressin, D. C., Neumann, A., Ellison, R., and Marlar, R. A. 1994. Correlation of antiphospholipid antibodies and protein S deficiency with thrombosis in HIV infected men. Blood Coagul Fibrinolysis, 5, 455–62.Google Scholar

Ho, D. D., Pomerantz, R. J., and Kaplan, J. C. 1987. Pathogenesis of infection with human immunodeficiency virus. N Engl J Med, 317, 278–86.Google Scholar

Hoffman, M., Berger, J. R., Nath, A., and Rayens, M. 2000. Cerebrovascular disease in young HIV infected black Africans in the Kwa-Zulu Natal Province of South Africa. J Neurovirol, 6, 229–36.Google Scholar

Hsue, P. Y., Lo, J. C., Franklin, A., et al. 2004. Progression of atherosclerosis as assessed by carotid intima–media thickness in patients with HIV infection. Circulation 109, 1603–8.Google Scholar

Joshi, V. V., Pawel, B., Connor, E., et al. 1987. Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol, 7, 261–75.Google Scholar

Kossorotoff, M., Touzé, E., Godon-Hardy, S., et al. 2006. Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. Neurology, 66, 1121–2.Google Scholar

Kumwenda, J. J., Mateyu, G., Kampondeni, S., et al. 2005. Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi. Stroke, 36, 960–4.Google Scholar

Kuwe, K., Llena, J. F., and Lyman, W. D. 1991. Human immunodeficiency virus-1 infection of the nervous system: An autopsy study of 268 adult, paediatric and foetal brains. Hum Pathol, 22, 700–10.Google Scholar

Lang, W., Miklossy, J., Deruaz, J. P., et al. 1989. Neuropathology of the acquired immune deficiency syndrome (AIDS): A report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (Berlin), 77, 379–90.Google Scholar

Libman, B. S., Quismorio, F. P. Jr., and Stimmler, M. M. 1995. Polyarteritis nodosa like vasculitis in human deficiency virus infection. J Rheumatol, 22, 351–5.Google Scholar

Maniker, A. L. and Hunt, C. D. 1996. Cerebral aneurysm in the HIV patient: A report of six cases. Surg Neurol, 46, 49–54.Google Scholar

Marcus, J. L., Leyden, W. A., Chaob, C. R., et al. 2014. HIV infection and incidence of ischemic stroke. AIDS, 28, 1911–1919.Google Scholar

Martin, C. M., Matlow, A. G., Chew, E., Sutton, D., and Pruzanski, W. 1989. Hyperviscosity syndrome in a patient with acquired immunodeficiency syndrome. Arch Intern Med, 149, 1435–6.Google Scholar

Martinez-Longoria, C. A., Morales-Aguirre, J. J., Villalobos-Acosta, C. P., Gomez-Barreto, D., and Cashat-Cruz, M. 2004. Occurrence of intracerebral aneurysm in an HIV-infected child: A case report. Pediatr Neurol, 31, 130–2.Google Scholar

Mazzoni, P., Chiriboga, C. A., Millar, W. S., and Rogers, A. 2000. Intracerebral aneurysms in human immunodeficiency virus infection: Case report and literature review. Pediatr Neurol, 23, 252–5.Google Scholar

Mizusawa, H., Hirano, A., Llena, J. F., and Shintaku, M. 1988. Cerebrovascular lesions in acquired immune deficiency syndrome (AIDS). Acta Neuropathol, 76, 451–7.Google Scholar

Mochan, A., Modi, M., and Modi, G. 2003. Stroke in black South African HIV positive patients, a prospective analysis. Stroke, 34, 10–15.Google Scholar

Mochan, A., Modi, M., and Modi, G. 2005. Protein S deficiency in HIV associated ischemic stroke: An epiphenomenon of HIV infection. J Neurol Neurosurg Psychiatry, 76, 1455–6.Google Scholar

Nagel, M. A., Cohrs, R. J., Mahalingam, R., et al. 2008. The varicella zoster virus vasculopathies: Clinical, CSF, imaging and virologic features. Neurology, 70, 853.Google Scholar

Nair, R., Chetty, R., Woolgar, J., Naidoo, N. G., and Robbs, J. V. 2001. Spontaneous arteriovenous fistula resulting from HIV arteritis. J Vasc Surg, 33, 186–7.Google Scholar

Nunes, M. L., Pinho, A. P., and Sfoggia, A. 2001. Cerebral aneurysmal dilatation in an infant with perinatally acquired HIV infection and HSV encephalitis. Arq Neuropsiquiatr, 59, 830.Google Scholar

Ovbiagele, B. and Nath, A. 2011. Increasing incidence of ischemic stroke in patients with HIV infection. Neurology, 76, 444.Google Scholar

Patel, V. B., Sacoor, Z., Francis, P., et al. 2005. Ischemic stroke in young HIV positive patients in Kwa-Zulu Natal, South Africa. Neurology, 65, 759–61.Google Scholar

Patsalides, A. D., Wood, L. V., Atac, G. K., et al. 2002. Cerebrovascular disease in HIV-infected pediatric patients. AJR Am J Roentgenol, 179, 999–1003.Google Scholar

Petito, C. K., Cho, E. S., Lemann, W., Naria, B. A., and Price, R. W. 1986. Neuropathology of acquired immunodeficiency syndrome (AIDS): An autopsy review. J Neuropathol Exp Neurol, 45, 635–46.Google Scholar

Pinto, A. N. 1996. AIDS and cerebrovascular disease. Stroke, 27, 538–43.Google Scholar

Qureshi, A. I. 2005. HIV infection and stroke: If not protein S deficiency then what explains the relationship. J Neurol Neurosurg Psychiatry, 76, 1331.Google Scholar

Qureshi, A. I., Janssen, R. S., Karon, J. M., et al. 1997. Human immunodeficiency virus infection and stroke in young patients. Arch Neurol, 54, 1150–3.Google Scholar

Rabinstein, A. A. 2003. Stroke in HIV-infected patients: A clinical perspective. Cerebrovasc Dis, 15, 37–44.Google Scholar

Rhodes, R. H. 1987. Histopathology of the central nervous system in the acquired immunodeficiency syndrome. Hum Pathol, 18, 636–43.Google Scholar

Rhodes, R. H. and Ward, J. M. 1991. AIDS meningoencephalomyelitis: Pathogenesis and changing neuropathological findings. Pathol Annu, 26, 247–76.Google Scholar

Rubbert, A., Bock, E., Schwab, J., et al. 1994. Anticardiolipin antibodies in HIV infection: Association with cerebral perfusion defects as detected by 99 mTc–HMPAO SPECT. Clin Exp Immunol, 98, 361–8.Google Scholar

Shahbaz, S., Manicardi, M., Guaraldi, G., and Raggi, P. 2015. Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk? World J Cardiol 7, 633–44.Google Scholar

Sico, J. J., Chang, C. C., So-Armah, K., et al. 2015. HIV status and the risk of ischemic stroke among men. Neurology, 84, 1933–40.Google Scholar

Sklar, P., and Masur, H. 2003. HIV infection and cardiovascular disease: Is there really a link? N Engl J Med, 349, 2065–7.Google Scholar

Sorice, M., Griggi, T., and Arceria, P. 1994. Protein S and HIV infection. The role of anticardiolysis and antiprotein S. Thromb Res, 73, 65–175.Google Scholar

Stahl, C. P., Wideman, C. S., and Spira, T. J. 1993. Protein S deficiency in men with long term human immunodeficiency virus infection. Blood, 81, 1801–7.Google Scholar

Statistics, SA. 2014. Mid-year population estimates 2014. See www.statssa.gov.za/publications/P0302/P03022014.pdf.Google Scholar

Sugerman, R. W., Church, J. A., and Goldsmith, J. C. 1996. Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J, 15, 106–11.Google Scholar

Tipping, B., de Villiers, L., Candy, S., and Wainwright, H. 2006. Stroke caused by human immunodeficiency virus-associated intracranial large-vessel aneurysmal vasculopathy. Arch Neurol, 63, 1640–2.Google Scholar

Tipping, B., de Villiers, L., Wainright, H., Candy, S., and Bryer, A. 2007. Stroke in human immunodeficiency virus infections. J Neurol, Neurosurg, and Psychiatr, 78, 1320–4.Google Scholar

Valeriano-Marcet, J., Ravichandran, L., and Kerr, L. D. 1990. HIV associated systemic necrotising vasculitis. J Rheumatol, 17, 1091–3.Google Scholar

Van den Dries, L. W., Gruters, R. A., Hovels-van der Borden, S. B., et al. 2015. Von Willebrand factor is elevated in HIV patients with a history of thrombosis. Front Microbiol, 6, 180.Google Scholar

Walker, R. W., Jusabani, A., Aris, E., et al. 2013. Stroke risk factors in an incident population in urban and rural Tanzania: A prospective, community-based, case control study. Lancet Glob Health, 1, e282–e288.Google Scholar

Worm, S. W., Sabin, C., Weber, R., et al. for the D:A:D Study Group. 2010. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. J Infect Dis, 201, 318–30.Google Scholar

Young, J., Xiao, Y., Moodie, E. M., et al. 2015. Effect of cumulating exposure to abacavir on the risk of cardiovascular disease events in patients from the Swiss HIV cohort study. J Acquir Immune Defic Syndr, 69, 413–21.Google Scholar

References

Ahmadi, J, Tung, H, Giannotta, SL, Destian, S. Monitoring of infectious intracranial aneurysms by sequential computed tomographic/magnetic resonance imaging studies. Neurosurgery, 1993, 32:45–50.Google Scholar

Asaithambi, G, Adil, MM, Qureshi, AI. Thrombolysis for ischemic stroke associated with infective endocarditis results from the nationwide inpatient sample. Stroke, 2013, 44:2917–19.Google Scholar

Aziz, F, Perwaiz, S, Penupolu, S, et al. Intracranial hemorrhage in infective endocarditis: A case report. J Thorac Dis, 2011, 3:134–7.Google Scholar

Baddley, JW, Benjamin, DK, Patel, M, et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis, 2008, 27:519–29.Google Scholar

Baddour, LM, Wilson, LM Infections of prosthetic valves and other cardiovascular devices: Intravascular devices. Mandel, Douglas and Bennett’s Principles and Practice and Infectious Diseases, 5th edn., eds. Mandell, GL, Bennett, JE, Dolin, R. Philadelphia, PA: Elsevier, 2005, 1022–1044.Google Scholar

Baddour, LM, Wilson, WR, Bayer, AS Infective endocarditis in adults: Diagnosis, antimicrobial therapy and management of complications. AHA scientific statement. Circulation, 2015, 132:1435–86.Google Scholar

Barsic, B, Dickerman, S, Krajinovic, V, et al. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis, 2013, 56:209–17.Google Scholar

Bashore, TM, Cabell, C, Fowler, V. Update on infective endocarditis. Curr Probl Cardiol, 2006, 31:274–352.Google Scholar

Bringham, WL Treatment of mycotic intracranial aneurysms. J Neurosurg, 1977, 46:428–37.Google Scholar

Castillo, JC, Anguita, MP, Ramirez, A, et al. Long term outcome of infective endocarditis in patients who were not drug addicts: A 10 year study. Heart, 2000, 83:525–30.Google Scholar

Champey, J, Pavese, P, Bouvaist, H, et al. Value of brain MRI in infective endocarditis: A narrative literature review. Eur J Clin Microbiol Infect Dis, 2016, 35:159–168.Google Scholar

Chan, KL, Dumesnil, JG, Cujec, B, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol, 2003, 42:775–80.Google Scholar

Corr, P, Wright, M, Handler, LC Endocarditis-related cerebral aneurysms: Radiologic changes with treatment. Neurosurgery, 1993, 32:45–9.Google Scholar

Dickerman, SA, Abrutyn, E, Barsic, B, et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE–PCS). Am Heart J, 2007, 154:1086–94.Google Scholar

Ducruet, AF, Hickman, ZL, Zacharia, BE, et al. Intracranial infectious aneurysms: A comprehensive review. Neurosurg Rev, 2010, 33:37–46.Google Scholar

Frazee, JG, Cahan, LD, Winter, J. Bacterial intracranial aneurysms. J Neurosurg, 1980, 53:633–41.Google Scholar

García-Cabrera, E, Fernández-Hidalgo, N, Almirante, B et al. Neurological complications of infective endocarditis: Risk factors, outcome, and impact of cardiac surgery – a multicenter observational study. Circulation, 2013, 127:2272–84.Google Scholar

Hart, RG, Foster, JW, Luther, MF, Kanter, MC Stroke in infective endocarditis. Stroke, 1990, 21:695–700.Google Scholar

Hart, RG, Kagan-Hallet, K, Joerns, S. Mechanism of intracranial hemorrhage in infective endocarditis. Stroke, 1987, 18:1046–56.Google Scholar

Heiro, M, Nikoskelainen, J, Engblom, E, et al. Neurologic manifestation of infective endocarditis. A 17-year experience in a teaching hospital in Finland. Arch Intern Med, 2000, 160:2781–7.Google Scholar

Hess, A, Klein, I, Iung, B et al. 44 Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. Am J Neuroradiol, 2013, 34:1579–84.Google Scholar

Hill, EE, Herijgers, P, Claus, P, et al. Infective endocarditis: changing epidemiology and predictors of 6 month mortality: A prospective cohort study. Eur Heart J, 2007, 28:196.Google Scholar

Hui, FK, Bain, M, Obuchowski, NA, et al. Mycotic aneurysm detection rates with cerebral angiography in patients with infective endocarditis. J NeuroIntervent Surg, 2015, 7:449–52.Google Scholar

Jeong-Min, K, Ji-Su, J, Yong-Won, K. Forced arterial suction thrombectomy of septic embolic middle cerebral artery occlusion due to infective endocarditis: An illustrative case and review of the literature. Neurointervention, 2014, 9:101–5.Google Scholar

Karchmer, AW. Infective endocarditis. In Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 7th edn. WB Saunders Co, 2005, pp. 1633–58.Google Scholar

Klein, I, Iung, B, Labreuche, J, et al. Cerebral microbleeds are frequent in infective endocarditis: A case control study. Stroke, 2009, 40:3461–5.Google Scholar

Lee, WK, Mossop, PJ, Little, AF, et al. Infected (mycotic) aneurysms: Spectrum of imaging appearances and management. Radiographics, 2008, 28:1853–68.Google Scholar

Merkler, AE, Chu, SY, Lerario, MP, et al. Temporal relationship between infective endocarditis and stroke. Neurology, 2015, 85:512–16.Google Scholar

Molinari, GF, Smith, L, Goldstein, MN, Satran, R. Pathogenesis of cerebral mycotic aneurysms. Neurology, 1973, 23:325–32.Google Scholar

Moreillon, P, Que, YA, Bayer, AS Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin North Am, 2002, 16:297–318.Google Scholar

Moreillon, P, Que, YA Infective endocarditis. Lancet, 2004, 363:139–49.Google Scholar

Ohira, S, Doi, K, Kawajiri, H, et al. Prediction of early postoperative cerebral hemorrhage in infective endocarditis patients using magnetic resonance imaging. Gen Thorac Cardiovasc Surg, 2014, 62:608–13.Google Scholar

Peters, PJ, Harrison, T, Lennox, JL A dangerous dilemma: Management of infectious intracranial aneurysms complicating endocarditis. Lancet Infect Dis, 2006, 6:742–48.Google Scholar

Rizzi, M, Ravasio, V, Carobbio, A, et al. Predicting the occurrence of embolic events: An analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI). BMC Infect Dis, 2014, 14:230.Google Scholar

Ruttmann, E, Willeit, J, Ulmer, H, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke, 2006, 37:2094.Google Scholar

Salgado, AV, Furlan, AJ, Keys, TF, et al. Neurologic complications of endocarditis: A 12-year experience. Neurology, 1989, 39:173–8.Google Scholar

Singhal, AB, Topcuoglu, MA, Buonanno, FS. Original contributions: Acute ischemic stroke patterns in infective and non bacterial thrombotic endocarditis: A diffusion-weighted magnetic resonance imaging study. Stroke, 2002, 33:1267–73.Google Scholar

Snygg-Martin, U, Gustafsson, L, Rosengren, L. Cerebrovascular complications in patients with left-sided infective endocarditis are common: A prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis, 2008, 47:23.Google Scholar

Steckelberg, JM, Murphy, JG, Ballard, D, et al. Emboli in infective endocarditis: The prognostic value of echocardiography. Ann Intern Med, 1991, 114:635–40.Google Scholar

Tornos, MP, Permanyer-Miralda, G, Olona, M, et al. Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med, 1992, 117:567.Google Scholar

Weinstein, LW, Brusch, JL. Infective Endocarditis. New York, NY: Oxford University Press, 1996.Google Scholar

Whitlock, RP, Sun, JC, Fremes, SE, et al. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, (2 Suppl):e576S.Google Scholar

Zanaty, M, Chalouhi, N, Starke, RM, et al. Endovascular treatment of cerebral mycotic aneurysm: A review of the literature and single center experience. BioMed Res Int, 2013, 151643.Google Scholar

References

Amlie-Lefond, C., Kleinschmidt-DeMasters, B. K., Mahalingam, R., Davis, L. E., and Gilden, D. H. 1995. The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol, 37, 784–90.Google Scholar

Askalan, R., Laughlin, S., Mayank, S., et al. 2001. Chickenpox and stroke in childhood: A study of frequency and causation. Stroke, 32, 1257–62.Google Scholar

Aurelius, E., Johansson, B., Skoldenberg, B., Staland, A., and Forsgren, M. 1991. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet, 337, 189–92.Google Scholar

Baudouin, E., and Lantuejoul, P. 1919. Les troublecas moteurs dans le zona. Gazette des Hopitaux.Google Scholar

Braun, K. P., Bulder, M. M., Chabrier, S., et al. 2009. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain, 132, 544–57.Google Scholar

Breuer, J., Pacou, M., Gauthier, A., and Brown, M. M. 2014. Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK. Neurology, 82, 206–12.Google Scholar

Cheng-Ching, E., Jones, S., Hui, F. K., et al. 2015. High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy. J Neurol Sci, 351, 168–73.Google Scholar

Ciccone, S., Faggioli, R., Calzolari, F., et al. 2010. Stroke after varicella-zoster infection: Report of a case and review of the literature. Pediatr Infect Dis J, 29, 864–7.Google Scholar

Devinsky, O., Cho, E. S., Petito, C. K., and Price, R. W. 1991. Herpes zoster myelitis. Brain, 114, 1181–96.Google Scholar

Ferry, G., Lonchampt, M., Pennel, L., et al. 1997. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett, 402, 111–5.Google Scholar

Frid, M.G., Brunetti, J. A., Burke, D. L., et al. 2006. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol, 168, 659–69.Google Scholar

Fukumoto, S., Kinjo, M., Hokamura, K., and Tanaka, K. 1986. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: Demonstration of the varicella-zoster-virus in the basilar artery lesions. Stroke, 17, 1024–8.Google Scholar

Gilden, D. H., Beinlich, B. R., Rubinstien, E. M., et al. 1994. Varicella-zoster virus myelitis: An expanding spectrum. Neurology, 44, 1818–23.Google Scholar

Gilden, D. H., Kleinschmidt-DeMasters, B. K., Wellish, M., et al. 1996. Varicella zoster virus, a cause of waxing and waning vasculitis: New England Journal of Medicine case 5–1995 revisited. Neurology, 47, 1441–6.Google Scholar

Gilden, D., White, T., Khmeleva, N., et al. 2015. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology, 84, 1948–55.Google Scholar

Gilden, D., White, T., Khmeleva, N., Boyer, P. J., and Nagel, M. A. 2016. VZV in biopsy-positive and -negative giant cell arteritis: Analysis of 100+ temporal arteries. Neurol Neuroimmunol Neuroinflamm, 3, e16.Google Scholar

Hartney, T., Birari, R., Venkataraman, S., et al. 2011. Xanthine oxidase-derived ROS upregulate Egr-a via ERK ½ in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia. PLoS One, 6, doi: 10.1371/journal/pone.0027531.Google Scholar

Haug, A., Mahalingam, R., Cohrs, R. J., et al. 2010. Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature. J Neurol Sci, 292, 85–8.Google Scholar

Heymann, A. D., Chodick, G., Karpati, T., et al. 2008. Diabetes as a risk factor for herpes zoster infection: Results of a population-based study in Israel. Infection, 36, 226–30.Google Scholar

Hsieh, C. C., Yen, M. H., Yen, C. H., and Lau, Y. T. 2001. Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc Res, 49, 135–45.Google Scholar

Itoh, Y., and Nagase, H. 1995. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem, 270, 16518–21.Google Scholar

Kang, J. H., Ho, J. D., Chen, Y. H., and Lin, H. C. 2009. Increased risk of stroke after a herpes zoster attack: A population-based follow-up study. Stroke, 40, 3443–8.Google Scholar

Langan, S. M., Minassian, C., Smeeth, L., and Thomas, S. L. 2014. Risk of stroke following herpes zoster: A self-controlled case-series study. Clin Infect Dis, 58, 1497–503.Google Scholar

Lanthier, S., Armstrong, D., Domi, T., and deVeber, G. 2005. Post-varicella arteriopathy of childhood: Natural history of vascular stenosis. Neurology, 64, 660–3.Google Scholar

Li, J., Li, W., Su, J., et al. 2003. Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: Possible relation to neurodegenerative diseases and strokes. Brain Res Bull, 62, 101–6.Google Scholar

Liberman, A. L., Nagel, M. A., Hurley, M. C., et al. 2014. Rapid development of 9 cerebral aneurysms in varicella-zoster virus vasculopathy. Neurology, 82, 2139–41.Google Scholar

Lin, H. C., Chien, C. W., and Ho, J. D. 2010. Herpes zoster ophthalmicus and the risk of stroke: A population-based follow-up study. Neurology, 74, 792–7.Google Scholar

Mathias, M., Nagel, M.A., Khmeleva, N., et al. 2013. VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash. J Neurol Sci, 325, 180–2.Google Scholar

Minassian, C., Thomas, S. L., Smeeth, L., et al. 2015. Acute cardiovascular events after herpes zoster: A self-controlled case series analysis in vaccinated and unvaccinated older residents of the United States. PLoS Med, 12, e1001919.Google Scholar

Miravet, E., Danchaivijitr, N., Basu, H., Saunders, D. E., and Ganesan, V. 2007. Clinical and radiological features of childhood cerebral infarction following varicella zoster virus infection. Dev Med Child Neurol, 49, 417–22.Google Scholar

Nagel, M. A., Forghani, B., Mahalingam, R., et al. 2007. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology, 68, 1069–73.Google Scholar

Nagel, M. A., Cohrs, R. J., Mahalingam, R., et al. 2008. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology, 70, 853–60.Google Scholar

Nagel, M. A., Traktinskiy, I., Azarkh, Y., et al. 2011. Varicella zoster virus vasculopathy: Analysis of virus-infected arteries. Neurology, 77, 364–70.Google Scholar

Nagel, M. A., Traktinskiy, I., Choe, A., Rempel, A., and Gilden, D. 2012. Varicella-zoster virus expression in the cerebral arteries of diabetic subjects. Arch Neurol, 69, 142–4.Google Scholar

Nagel, M. A., Bennett, J. L., Khmeleva, N., et al. 2013a. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology, 80, 2017–21.Google Scholar

Nagel, M. A., Choe, A., Khmeleva, N., et al. 2013b. Search for varicella zoster virus and herpes simplex virus-1 in normal human cerebral arteries. J Neurovirol, 19, 181–5.Google Scholar

Nagel, M.A., Khmeleva, N., Boyer, P.J., Choe, A., Bert, R., and Gilden, D. 2013c. Varicella zoster virus in the temporal artery of a patient with giant cell arteritis. J Neurol Sci, 335, 228–30.Google Scholar

Nagel, M. A., Russman, A. N., Feit, H., et al. 2013d. VZV ischemic optic neuropathy and subclinical temporal artery infection without rash. Neurology, 80, 220–2.Google Scholar

Nagel, M. A., Traktinskiy, I., Stenmark, K. R., et al. 2013e. Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries. Neurology, 80, 62–8.Google Scholar

Nagel, M. A., Khmeleva, N., Choe, A., Gutierrez, J., and Gilden, D. 2014. Varicella zoster virus (VZV) in cerebral arteries of subjects at high risk for VZV reactivation. J Neurol Sci, 339, 32–4.Google Scholar

Nagel, M. A., White, T., Khmeleva, N., et al. 2015. Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol, 72, 1281–7.Google Scholar

Okada, Y., and Nakanishi, I. 1989. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin G. FEBS Lett, 249, 353–6.Google Scholar

Sabry, A., Hauk, P. J., Jing, H., et al. 2014. Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency. J Allergy Clin Immunol, 133, 1225–7.Google Scholar

Salazar, R., Russman, A. N., Nagel, M. A., et al. 2011. Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol, 68, 517–20.Google Scholar

Siddiqi, S. A., Nishat, S., Kanwar, D., et al. 2012. Cerebral venous sinus thrombosis: Association with primary varicella zoster virus infection. J Stroke Cerebrovasc Dis, 21, 917–4.Google Scholar

Sreenivasan, N., Basit, S., Wohlfahrt, J., et al. 2013. The short- and long-term risk of stroke after herpes zoster: A nationwide population-based cohort study. PLoS One, 8, e69156.Google Scholar

Stenmark, K.R., Frid, M.G., Yeager, M., et al. 2012. Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change. Pulm Circ, 2, 3–14.Google Scholar

Stevens, D. A., Ferrington, R. A., Jordan, G. W., and Merigan, T. C. 1975. Cellular events in zoster vesicles: Relation to clinical course and immune parameters. J Infect Dis, 131, 509–15.Google Scholar

Sundström, K., Weibull, C. E., Soderberg-Lofdal, K., et al. 2015. Incidence of herpes zoster and associated events including stroke: A population-based cohort study. BMC Infect Dis, 15, 488.Google Scholar

Weber, D. S., Taniyama, Y., Rocic, P., et al. 2004. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res, 94, 1219–26.Google Scholar

Yawn, B. P., Wollan, P. C., Nagel, M. A., and Gilden, D. 2016. Risk of stroke and myocardial infarction after herpes zoster in older adults in a US community population. Mayo Clin Proc, 91, 33–44.Google Scholar

Book contents

Section 1 - Infectious Conditions

Summary

Access options

References

References

References

References

References

References

References

References

References

References

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive